Document:

Exhibit 10.1

 

EXECUTION VERSION

 

	JPMORGAN CHASE BANK, N.A. 

383 Madison Avenue 

New York, New York 10170	GOLDMAN SACHS BANK USA

200 West Street

New York, New York 10282

 

Highly Confidential

 

January 5, 2017

 

Gartner, Inc.

56 Top Gallant Road

Stamford, Connecticut 06902

 

Attention: Craig Safian

 

Project Cobra

Commitment Letter

 

Ladies and Gentlemen:

 

You have advised JPMorgan Chase
Bank, N.A. (“JPMorgan Chase Bank”) and Goldman Sachs Bank USA (“Goldman Sachs”; Goldman Sachs,
together with JPMorgan Chase Bank and any person that becomes a party hereto as a “Commitment Party” as contemplated
in Section 2 below, the “Commitment Parties,” “we” or “us”) that Gartner,
Inc., a Delaware corporation (the “Borrower” or “you”), intends to acquire (the “Acquisition”)
the company you have previously described to us under the code name “Cobra” (the “Target”). You
have further advised us that, in connection with the foregoing, you intend to consummate the transactions described in the Transaction
Description attached hereto as Exhibit A (the “Transaction Description”). Capitalized terms used but
not defined herein shall have the meanings assigned to them in the Transaction Description and in the Exhibits attached hereto
(such Exhibits, together with this commitment letter, collectively, the “Commitment Letter”).

 

1.     Commitments.

 

Based upon the foregoing, on
the terms set forth in this Commitment Letter and subject only to the conditions expressly set forth in Exhibit H of this
Commitment Letter, (a) JPMorgan Chase Bank is pleased to advise you of its several commitments to provide (i) if the requisite
consent of the existing lenders under the Existing Credit Facilities (the “Existing Lenders”) to the Specified
Amendment is not obtained under the Existing Credit Facilities on or prior to the Closing Date, 100% of the Backstop Facilities
to replace the Existing Credit Facilities upon the terms set forth in the Senior Secured Backstop Facilities Summary of Principal
Terms and Conditions attached hereto as Exhibit C (the “Backstop Facilities Term Sheet”), (ii) 50% of
the aggregate principal amount of the Term Loan B Facility upon the terms set forth in the Term Loan B Facility Summary of Principal
Terms and Conditions attached hereto as Exhibit D (the “Term Loan B Facility Term Sheet”), (iii) 50%
of the aggregate principal amount of the 364-day Bridge Facility upon the terms set forth in the 364-day Bridge Facility Summary
of Principal Terms and Conditions attached hereto as Exhibit E (the “364-day

    	 

    	

    

Bridge Facility Term Sheet”)
and (iv) 50% of the aggregate principal amount of the HY Bridge Facility upon the terms set forth in the HY Bridge Facility Summary
of Principal Terms and Conditions attached hereto as Exhibit F (the “HY Bridge Facility Term Sheet,”
together with the Transaction Description, the Summary of Specified Amendment attached hereto as Exhibit B, the Backstop
Facilities Term Sheet, the Term Loan B Facility Term Sheet, the 364-day Bridge Facility Term Sheet, the Senior Unsecured Notes
Summary of Principal Terms and Conditions attached hereto as Exhibit G and the Conditions Precedent to the Closing attached
hereto as Exhibit H, the “Term Sheets”), (b) Goldman Sachs is pleased to advise you of its several commitments
to provide (i) 50% of the aggregate principal amount of the Term Loan B Facility upon the terms set forth in the Term Loan B Facility
Term Sheet, (ii) 50% of the aggregate principal amount of the 364-day Bridge Facility upon the terms set forth in the 364-day Bridge
Facility Term Sheet and (iii) 50% of the aggregate principal amount of the HY Bridge Facility upon the terms set forth in the HY
Bridge Facility Term Sheet.

 

2.     Titles & Roles.

 

You hereby appoint (a) JPMorgan
Chase Bank to act, and JPMorgan Chase Bank hereby agrees to act as, (i) lead arranger and bookrunner (in such capacities, the “Backstop
Lead Arranger”) and the sole administrative agent for the Backstop Facilities, (ii) joint lead arranger and bookrunner
(in such capacities, a “Term Loan B Lead Arranger”) and the sole administrative agent for the Term Loan B Facility,
(iii) joint lead arranger and bookrunner (in such capacities, a “364-day Bridge Lead Arranger”) and the sole
administrative agent for the 364-day Bridge Facility and (iv) joint lead arranger and bookrunner (in such capacities, a “HY
Bridge Lead Arranger”) for the HY Bridge Facility; provided that JPMorgan Chase Bank’s responsibilities as lead
arrangers and bookrunners for the transactions described in this Agreement may be performed by its affiliate, J.P. Morgan Securities
LLC, and (b) Goldman Sachs to act, and Goldman Sachs hereby agrees to act as, (i) joint lead arranger and bookrunner (in such capacities,
a “Term Loan B Lead Arranger”) for the Term Loan B Facility, (ii) joint lead arranger and bookrunner (in such
capacities, a “364-day Bridge Lead Arranger”) for the 364-day Bridge Facility and (iii) joint lead arranger
and bookrunner (in such capacities, a “HY Bridge Lead Arranger”) and the sole administrative agent for the HY
Bridge Facility, in each case on the terms set forth in this Commitment Letter and subject only to the applicable conditions expressly
set forth in the Exhibits to this Commitment Letter.

 

You also hereby appoint JPMorgan
Chase Bank to act, and JPMorgan Chase Bank hereby agrees to act, as lead arranger and bookrunner (in such capacities, the “Amendment
Lead Arranger,” and together with the Backstop Lead Arranger, each Term Loan B Lead Arranger, each 364-day Bridge Lead
Arranger and each HY Bridge Lead Arranger, the “Lead Arrangers”) for the arrangement of the Specified Amendment.
In its capacity as the Amendment Lead Arranger, JPMorgan Chase Bank agrees to use its commercially reasonable efforts to obtain
the requisite consent of the Existing Lenders to the Specified Amendment, it being understood and agreed that (a) the Amendment
Lead Arranger shall endeavor to obtain such requisite consent within 45 days after the date hereof and (b) if the requisite consent
for the Specified Amendment shall not have been obtained on or prior to the date that is 45 days after the date hereof, JPMorgan
Chase Bank may at its discretion cease seeking to obtain the requisite consents for the Specified Amendment. You acknowledge that
this Commitment Letter is neither

    	2

    	

    

an expressed nor an implied commitment by the Amendment
Lead Arranger or any of its affiliates to consummate the Specified Amendment (or any part thereof) or to hold or purchase any existing
loans or commitments under the Existing Credit Facilities in order to facilitate the consummation of the Specified Amendment (or
any part thereof), nor is it a guarantee with respect to the outcome of the Specified Amendment. The obligations of the Amendment
Lead Arranger to endeavor to arrange the requisite consent to the Specified Amendment shall not require the Amendment Lead Arranger
or any of its affiliates to share any of the fees payable to it in connection with the Transactions (or otherwise expend any amounts)
in order to achieve such consents.

 

On or prior to the date that
is fifteen (15) calendar days after the date of this Commitment Letter (or such later date as the Commitment Parties may agree),
you may appoint up to four additional financial institutions as agents, co-agents, lead arrangers, bookrunners, managers or arrangers
and up to three more additional financial institutions as co-managers (but not as lead arrangers or bookrunners) in respect of
the Facilities and the Specified Amendment (any such financial institution, an “Additional Arranger”) and/or
confer additional titles in respect of the Facilities and the Specified Amendment on the Additional Arrangers in a manner and with
economics determined by you in consultation with us; provided that: (i) each such Additional Arranger or its affiliates
shall commit to a pro rata portion of each Facility, based on the percentage of economics that can be reallocated as provided below
(and the economics allocated to such Additional Arranger or its affiliates with respect to any Facility will be proportionate to
the percentage of such Facility committed to be provided by such Additional Arranger and its affiliates); provided that
no Additional Arranger shall be required to commit to a portion of the Backup Facilities; (ii) the Commitment Parties’ commitments
hereunder are reduced ratably by the aggregate amount of the commitments allocated to the Additional Arrangers; (iii) no Additional
Arranger shall be allocated a greater percentage of the commitments with respect to any Facility (and corresponding compensatory
economics) than JPMorgan Chase Bank and Goldman Sachs, respectively; (iv) not more than 30% of the aggregate commitments (and corresponding
compensatory economics) with respect to the 364-day Bridge Facility shall be so allocated and not more than 35% of the aggregate
commitments (and corresponding compensatory economics) with respect to each of the Term Loan B Facility and the HY Bridge Facility
shall be so allocated; (v) no Additional Arranger or its affiliates shall be allocated a greater percentage of the compensatory
economics in respect of the Specified Amendment than the percentage of compensatory economics allocated to it, in accordance with
the foregoing provisions, in respect of the Facilities; (vi) such Additional Arrangers shall assume the obligations of the “Commitment
Parties” and, if applicable, the “Lead Arrangers” hereunder on terms reasonably acceptable to the Commitment
Parties and you (including the execution and delivery by such Additional Arrangers of customary joinder documentation) and, thereafter,
each such Additional Arranger shall constitute a “Commitment Party” and, if applicable, a “Lead Arranger”
under this Commitment Letter and under the Arranger Fee Letter (as defined below); and (vii) no Additional Arrangers shall be permitted
with respect to the Backstop Facilities. The commitments and other obligations of the Commitment Parties hereunder are several
and not joint. Subject to the second preceding sentence, no other agents, co-agents, arrangers, co-arrangers, bookrunners, managers
or co-managers will be appointed, no other titles will be awarded and no compensation (other than compensation expressly contemplated
by this Commitment Letter or the Fee Letters (as defined below)) will be paid by you or your

    	3

    	

    

subsidiaries to any Lender as consideration for
its participation in the Facilities or to any Existing Lender as consideration to its consent to the Specified Amendment, in each
case, unless you and we shall so agree. It is further agreed that JPMorgan Chase Bank will have “left” placement and
Goldman Sachs will have “right” placement in any marketing materials or other documentation used in connection with
the Term Loan B Facility and the 364-day Bridge Facility and that Goldman Sachs will have “left” placement and JPMorgan
Chase Bank will have “right” placement in any marketing materials or other documentation used in connection with the
HY Bridge Facility and the Notes. Additional Arrangers are to be listed in alphabetical order beneath JP Morgan Chase Bank and
Goldman Sachs on any marketing materials used in connection with the Facilities and the Notes.

 

3.     Syndication.

 

The Commitment Parties reserve
the right, prior to or after the execution of the definitive documentation for the Facilities, to syndicate the Facilities to one
or more financial institutions or other lenders in consultation with and reasonably acceptable to you (together with the Commitment
Parties, the “Lenders”), it being understood that the Permitted Lenders (as defined below) are reasonably acceptable
to you, and it being understood that the Facilities may be separately syndicated. The Commitment Parties agree not to syndicate
the Facilities to, or assign their commitments under the Facilities to, (a) certain banks, financial institutions and other institutional
lenders that have been specified by you in writing to the Lead Arrangers at any time prior to the date hereof, (b) any of your
competitors that have been specified to the Lead Arrangers by you in writing before the Closing Date or to the applicable Administrative
Agent by you in writing after the Closing Date at any time and from time to time and (c) in the case of each of clauses (a) and
(b), any of their respective affiliates (other than any bona fide debt funds) that are either (x) identified in writing to the
Lead Arrangers or, after the Closing Date, the applicable Administrative Agent by you from time to time or (y) clearly identifiable
as affiliates of such persons on the basis of such affiliate’s name (the foregoing persons, collectively, the “Disqualified
Lenders”), it being understood and agreed that the foregoing provisions shall not apply retroactively to disqualify any
person that shall have become a Disqualified Lender after the date of the launch of the general syndication for any Facility if
such person shall have become a Lender or participant (or shall have been allocated a commitment as part of the general syndication
of such Facility) prior thereto, but shall disqualify such person from taking any further assignment or participation thereafter).
Notwithstanding our right to syndicate the Facilities and to receive commitments with respect thereto, other than as expressly
provided in the final paragraph of Section 2 above, (A) no Commitment Party shall be relieved, released or novated from its obligations
hereunder (including its obligation to fund the Facilities on the Closing Date) in connection with any syndication, assignment
or participation of the Facilities until after the Closing Date has occurred, (B) no assignment or novation shall become effective
(as between you and any of us) with respect to all or any portion of any Commitment Party’s commitments in respect of the
Facilities until the initial funding of the Facilities by such Commitment Party and (C) unless you otherwise agree in writing,
each Commitment Party shall retain exclusive control over all rights and obligations with respect to its commitments in respect
of the Facilities and this Commitment Letter, including all rights with respect to consents, modifications, supplements, waivers
and amendments, until after the Closing Date has occurred. For purposes of this Commitment Letter, “Permitted Lender”
shall mean (i) a Commitment Party

    	4

    	

    

and any of its controlled affiliates,
(ii) any person that (A) is an Existing Lender as of the date hereof or (B) is a commercial or investment bank or an insurance
company that, in each case under this clause (B), at the time of such assignment has a long-term senior unsecured, non-credit enhanced
debt rating of at least BBB by Standard & Poor’s Financial Services LLC (“S&P”) or Baa2 by Moody’s
Investors Service, Inc. (“Moody’s”) and is not a Disqualified Lender or (iii) any other person to which
you shall have consented in writing.

 

Until the earlier to occur of
(a) the date on which a Successful Syndication (as defined in the Arranger Fee Letter) shall have occurred and (b) 60 days after
the Closing Date (such period, the “Syndication Period”), you agree to assist us in arranging the Specified
Amendment and completing syndications of the Facilities that are reasonably satisfactory to the Lead Arrangers and you. Such assistance
shall include (i) your using commercially reasonable efforts to ensure that the arrangement and syndication efforts benefit from
your and your subsidiaries’ existing banking relationships and, to the extent practical and appropriate, the existing banking
relationships of the Target and its subsidiaries, (ii) direct contact between your senior management, on the one hand, and the
Existing Lenders and the proposed Lenders, on the other hand (and subject to your rights under the Acquisition Agreement (as defined
in Exhibit A hereto), your using commercially reasonable efforts to ensure such contact between the senior management of
the Target, on the one hand, and the Existing Lenders and the proposed Lenders, on the other hand), at such times during normal
business hours as are mutually agreed, (iii) your assistance (and subject to your rights under the Acquisition Agreement, your
using commercially reasonable efforts to cause the Target and its subsidiaries to assist) in prompt preparation of customary confidential
information memoranda (the “Confidential Information Memoranda”) and other customary marketing materials to
be used in connection with the arrangement and syndication efforts by providing information and other customary materials reasonably
requested by us in connection therewith (such marketing materials and the Confidential Information Memoranda, collectively, with
the Term Sheets and the information and projections referred to in the next succeeding paragraph, the “Information Materials”),
(iv) the hosting, with the Lead Arrangers, of one or more meetings of and conference calls with the Existing Lenders and the prospective
Lenders, at times and locations mutually agreed upon and upon reasonable advance notice (provided that, without your consent,
there shall be no more than one general bank meeting for the Facilities (other than the Term Loan B Facility) and one general bank
meeting for the Term Loan B Facility), (v) your ensuring that there are not any competing issues of debt securities or commercial
bank or other credit facilities (including incremental commitments or loans or extensions of existing commitments or loans) of
you or your subsidiaries (and, subject to your rights under the Acquisition Agreement, your using commercially reasonable efforts
to ensure the same with respect to the Target and its subsidiaries) offered, placed, announced or arranged (excluding the Facilities,
the Notes or any other debt securities issued for the purpose of consummating the Acquisition), to the extent such offering, placement,
announcement or arrangement could reasonably be expected to materially impair the arrangement of the Specified Amendment, the primary
syndication of the Facilities or the marketing of the Notes, in each case, without the prior written consent of the Lead Arrangers
(such consent not to be unreasonably withheld or delayed) (it being understood that the Borrower’s and its subsidiaries’
deferred purchase price obligations, ordinary course working capital facilities (other than any new or incremental revolving credit
facilities), borrowings under existing facilities (other than under any incremental commitments established or extended under such
facilities after the date hereof) and

    	5

    	

    

ordinary course capital leases,
purchase money and equipment financings, and any indebtedness of the Target and its subsidiaries permitted to be incurred and remain
outstanding pursuant to the Acquisition Agreement will not, in each case, be deemed to materially impair the arrangement of the
Specified Amendment, the primary syndication of the Facilities or the marketing of the Notes), and (vi) prior to the launch of
the syndication of the Facilities and the commencement of the marketing period for the Notes, using your commercially reasonable
efforts to (x) obtain an updated monitored public corporate credit rating from S&P and an updated monitored public corporate
family rating from Moody’s, in each case, with respect to the Borrower and (y) obtain public ratings of the Term Loan B Facility,
the 364-day Facility and the Notes from each of S&P and Moody’s. Such assistance shall also include, in respect of the
Specified Amendment, your cooperating with the Amendment Lead Arranger in seeking to obtain the requisite consent of the Existing
Lenders to the Specified Amendment (including, without limitation, by negotiating in good faith the terms of the Specified Amendment
(including considering in good faith such amendments of the Existing Credit Facility as may be reasonably requested by the Existing
Lenders in respect of the Acquisition and the Target and its subsidiaries and such assignments under the Existing Credit Facility
as the Amendment Lead Arranger may request be made to facilitate obtaining such requisite consent) and your entering into the Specified
Amendment at such time as the Amendment Lead Arranger shall advise you that the Existing Lenders are willing to provide the requisite
consent thereto. Without limiting your obligations to assist with arrangement and syndication efforts as set forth above, each
Commitment Party agrees that neither the obtaining of the requisite consent to the Specified Amendment nor the commencement or
the completion of the syndication of any Facility or the receipt of any rating referred to above is a condition to its commitment
hereunder. The financial statements identified in paragraphs 3, 4 and 5 of Exhibit H hereto are the only financial statements
the delivery of which are conditions to the availability of the Facilities.

 

The Lead Arrangers will manage,
in consultation with you, all aspects of the syndication of the Facilities and the arrangement of the Specified Amendment, including,
without limitation, selection of Lenders, determination of when the Lead Arrangers will approach the Existing Lenders or potential
Lenders and the time of acceptance of the Lenders’ commitments or the Existing Lenders’ consents and any naming rights,
and will, subject to your consent in the case of any Lender that is not a Permitted Lender, determine the Lenders whose commitments
will be accepted, the final allocations of the commitments among the Lenders and the amount and distribution of fees among the
Existing Lenders and the Lenders. To assist the Lead Arrangers in their syndication and arrangement efforts, you agree promptly
to prepare and provide to the Lead Arrangers (and, subject to your rights under the Acquisition Agreement, to use commercially
reasonable efforts to cause the Target to prepare and provide to the Lead Arrangers) all customary information with respect to
you, the Target and your and its subsidiaries and the Transactions, including, without limitation, all customary financial information
and the projections of and other forward-looking information with respect to you, the Target and your and its subsidiaries after
the Transactions (the “Projections”), that the Lead Arrangers may reasonably request in connection with the
structuring, arrangement and syndication of the Facilities and the arrangement of the Specified Amendment.

 

You acknowledge that (a) subject
to the confidentiality obligations contained herein, the Commitment Parties on your behalf will make available the Information
Materials

    	6

    	

    

and other information relating
to the Specified Amendment and the Facilities, including drafts and final definitive documentation with respect thereto, to the
Existing Lenders and the proposed Lenders by posting the Information Materials and such other information on IntraLinks, SyndTrak,
Datasite or another similar electronic system, in accordance with the Lead Arrangers’ standard syndication practices (including
hard copy and via electronic transmissions), it being understood and agreed that all information so disseminated or provided shall
continue to be subject to the terms of any written confidentiality agreements heretofore or hereafter executed by the Lead Arrangers
and the confidentiality provisions set forth herein, and (b) certain Existing Lenders and prospective Lenders (such Lenders, “Public
Lenders”; all other Existing Lenders or Lenders, “Private Lenders”) may have personnel that do not
wish to receive Private Lender Information (as defined below). If requested, you agree to assist in the preparation of a version
of the Confidential Information Memoranda (and related marketing materials) and presentations to be distributed to Public Lenders
in connection with the arrangement of the Specified Amendment and the syndication of the Facilities consisting exclusively of information
and documentation that is either (i) publicly available or (ii) not material with respect to you, your subsidiaries, the Target
or its subsidiaries or any securities of any of the foregoing for purposes of the United States Federal or state securities laws
(the information and documentation described in clauses (i) and (ii) being “Public Lender Information”). Any
information and documentation that is not Public Lender Information is referred to herein as “Private Lender Information.”
It is understood that in connection with your assistance described above, customary authorization letters will be included in any
Confidential Information Memorandum that authorize the distribution of such Confidential Information Memorandum to the Existing
Lenders or prospective Lenders, containing a representation from you to the Lead Arrangers that the public-side version does not
include any Private Lender Information and a customary “10b-5” representation consistent with Section 6 below (and
you shall, subject to your rights under the Acquisition Agreement, use commercially reasonable efforts to cause the Target to deliver
customary authorization letters containing such representations from the Target to the Lead Arrangers, it being understood that
the customary “10b-5” representation by the Target, in the case of authorization letters delivered by the Target, shall
not be qualified by knowledge), and exculpating (x) the Commitment Parties and their respective affiliates with respect to any
liability related to the use of the contents of such Confidential Information Memorandum or any related marketing material by the
recipients thereof and (y) you or your subsidiaries with respect to any liability related to the misuse of the contents of such
Confidential Information Memorandum. You agree that the Commitment Parties on your behalf may distribute the following documents
to all Public Lenders and Private Lenders (other than Disqualified Lenders), unless, after having been given a reasonable opportunity
to review such documents, you advise the Commitment Parties that such material should only be distributed to Private Lenders: (a)
drafts and final definitive documentation with respect to the Facilities and the Specified Amendment; (b) administrative materials
prepared by the Lead Arrangers for the Existing Lenders or prospective Lenders (such as a lender meeting invitation, bank allocation,
if any, and funding and closing memoranda); and (c) notification of changes in the terms of the Facilities or the Specified Amendment.
If you advise us in writing that any of the foregoing items should be distributed only to Private Lenders, then the Commitment
Parties will not distribute such materials to Public Lenders without further discussions with you. At our request, you shall designate
information to be distributed solely to Public Lenders by clearly and

    	7

    	

    

conspicuously designating the
same as “PUBLIC” (it is understood that you shall not otherwise be under any obligation to designate information as
“PUBLIC”).

 

For the avoidance of doubt,
you will not be required to provide any information to the extent that the provision thereof would violate any law, rule or regulation,
or any obligation of confidentiality binding on you or your affiliates.

 

4.     Fees.

 

As consideration for our commitments
hereunder and our undertakings to arrange, manage, structure and syndicate the Facilities and arrange the Specified Amendment,
you agree to pay to us the fees and fulfill the other obligations set forth in the Term Sheets and in the arranger fee letter among
us and you dated the date hereof (the “Arranger Fee Letter”) and each of the administrative agent fee letters
among you and JPMorgan Chase Bank and Goldman Sachs, respectively, dated the date hereof (the “Administrative Agent Fee
Letters” and, together with the Arranger Fee Letter, the “Fee Letters”).

 

5.     Conditions Precedent.

 

Our commitments and agreements
hereunder are subject solely to the satisfaction or waiver of the applicable conditions expressly stated in Exhibit H hereto;
it being understood that there are no conditions (implied or otherwise) to the commitments hereunder (including compliance with
the terms of the Commitment Letter, the Fee Letters and the Loan Documents (as defined below)) other than those that are expressly
stated in Exhibit H (and upon satisfaction or waiver of such conditions, the initial funding under the Facilities shall
occur). Notwithstanding anything in this Commitment Letter, the Fee Letters, the Loan Documents or any other letter agreement or
other undertaking to the contrary, (a) the only representations and warranties the accuracy of which shall be a condition to availability
of the Facilities on the Closing Date shall be (i) the Acquisition Agreement Representations (as defined below) and (ii) the Specified
Representations (as defined below) and (b) the terms of the Loan Documents shall be in a form such that they do not impair the
availability of the Facilities on the Closing Date if the applicable conditions expressly set forth in Exhibit H hereto
are satisfied (or waived by the Commitment Parties) (it being understood that, to the extent any collateral (including the grant
or perfection of any security interest, other than (x) the delivery of certificates evidencing equity interests for the Borrower’s
wholly-owned direct and indirect material U.S. subsidiaries (which are not direct or indirect subsidiaries of entities not organized
in the U.S.), including the Target, to the extent certificated and required to be pledged as set out in the Term Sheets, but not
including equity interests of the Target’s subsidiaries and (y) any Collateral the security interest in which may be perfected
by the filing of a Uniform Commercial Code financing statement for entities organized in the U.S.) referred to in the Term Sheets
is not or cannot reasonably be provided on the Closing Date after your use of commercially reasonable efforts to do so or without
undue burden or expense, then the provision of such collateral and perfection therein shall not constitute a condition precedent
to the availability of the Facilities on the Closing Date, but may instead be provided or perfected within 45 days after the Closing
Date (in each case, subject to extensions to be reasonably agreed upon by the applicable Administrative Agent)). For purposes of
the foregoing, (A) “Acquisition Agreement Representations” means such

    	8

    	

    

representations and warranties
made by the Target in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that you
(or your applicable subsidiaries) have the right (taking into account any applicable cure periods) to terminate your (or its) obligation
to consummate the Acquisition under the Acquisition Agreement or the right not to consummate the Acquisition pursuant to the Acquisition
Agreement as a result of a breach of such representations and warranties, and (B) “Specified Representations”
means the representations and warranties of the Loan Parties set forth in the Loan Documents relating to corporate or other organizational
existence of the Loan Parties, organizational power and authority (as to execution, delivery and performance of the Loan Documents)
of the Loan Parties, the due authorization, execution, delivery and enforceability of the Loan Documents by the Loan Parties, in
each case as it relates to entering into and performance of the Loan Documents against or by the Loan Parties, the Loan Documents
not conflicting with the Loan Parties’ respective organizational documents, solvency as of the Closing Date (after giving
effect to the Transactions) of the Borrower and its restricted subsidiaries on a consolidated basis (such representation and warranty
to be consistent with the solvency certificate substantially in the form set forth in Exhibit I hereto), Federal Reserve
margin regulations, Investment Company Act status, subject to permitted liens and the limitations set out in the preceding sentence,
the creation, validity and perfection of the security interests granted in the collateral (solely in the case of the Backstop Facility
and the Term Loan B Facility,), compliance with Patriot Act and use of proceeds not violating OFAC and FCPA. The provisions in
this Section 5 are referred to as the “Limited Conditionality Provisions.” For the avoidance of doubt, “Loan
Documents” as used in this Commitment Letter shall mean (i) if the Specified Amendment is not obtained prior to the Closing
Date, the Backstop Documentation, the Term Loan B Documentation, the 364-day Bridge Documentation and the HY Bridge Documentation
and (ii) if the Specified Amendment is obtained prior to the Closing Date, the Term Loan B Documentation, the 364-day Bridge Documentation
and the HY Bridge Documentation only.

 

6.     Information.

 

You hereby represent and warrant
(but the accuracy of such representation and warranty shall not be a condition to the commitments hereunder, the arrangements of
the Specified Amendment or the funding of the Facilities) that (a) all written information (other than the Projections, estimates
and information of a general economic, forward looking or industry nature and limited to your knowledge prior to the Closing Date
as to the Target and its subsidiaries) (the “Information”) that has been or will be made available to the Commitment
Parties by you or any of your representatives or affiliates on your behalf, when taken as a whole, is or will be, when furnished,
correct in all material respects and does not or will not, as the case may be, taken as a whole, contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements contained therein not materially misleading
in light of the circumstances under which such statements are made (when taken as a whole and after giving effect to all supplements
and updates thereto) and (b) the Projections that have been made or will be made available to the Commitment Parties by you or
any of your representatives or affiliates on your behalf and that have or will be made available to us or any Lender in connection
with the Transactions have been or will be, as the case may be, prepared in good faith based upon assumptions believed by the preparer
thereof to be reasonable at the time so made available (it being recognized by us that such Projections are subject to significant

    	9

    	

    

uncertainties and contingencies,
many of which are beyond your control, are not to be viewed as facts, that actual results during the period or periods covered
by any such Projections may differ from the projected results and such differences may be material, and that no assurance can be
given that any projection will be realized). You agree to supplement the Information and the Projections from time to time until
the later of the Closing Date and the completion of the Syndication Period, so that the representations and warranties in the preceding
sentence each remain correct. In arranging the Facilities and the Specified Amendment, including the syndication of the Facilities,
we will be entitled to use and rely primarily on the Information and the Projections without responsibility for independent verification
thereof.

 

7.     Expenses.

 

Subject to and contingent upon
Closing, you agree to pay or reimburse each Commitment Party for all reasonable and documented out-of-pocket fees and expenses
(including, without limitation, expenses of such Commitment Party’s due diligence investigation, syndication expenses, travel
expenses and reasonable fees, disbursements and other charges of outside counsel identified in the Term Sheets and one local counsel
(limited to a single firm of counsel for all of the Commitment Parties) retained in any material relevant jurisdiction to the extent
reasonably necessary) incurred by such Commitment Party or its affiliates (whether incurred before or after the date hereof) in
connection with the Facilities and the Specified Amendment and the preparation, negotiation, execution and delivery of this Commitment
Letter, the Fee Letters, the Loan Documents and any security arrangements in connection therewith and any such fees and expenses
incurred in connection with the enforcement of any of the Commitment Parties’ rights and remedies hereunder. The provisions
of this Section 7 will be superseded by the definitive documentation for the Facilities.

 

8.     Indemnification.

 

You agree to indemnify and hold
harmless each Commitment Party and its affiliates and each Commitment Party’s and its affiliates’ respective officers,
directors, employees, advisors, agents, other representatives, controlling persons, members, partners and successors and permitted
assigns (each Commitment Party and each such other person being an “Indemnified Person”) from and against any
and all losses, claims, damages, liabilities and expenses, joint or several, to which any such Indemnified Person may become subject
arising out of or in connection with this Commitment Letter, the Fee Letters, the Term Sheets, the Transactions and the other transactions
contemplated hereby, the Specified Amendment, the Facilities, the use of proceeds therefrom and any claim, litigation, investigation
or proceeding (any of the foregoing, a “Proceeding”) relating to any of the foregoing, regardless of whether
any such Indemnified Person is a party thereto and regardless of whether a Proceeding is brought by a third party or by you, the
Target or any of your or its respective affiliates or equity holders or any other person, and to reimburse each such Indemnified
Person upon demand for any reasonable and documented out-of-pocket expenses incurred in connection with investigating, defending
or testifying in connection with any of the foregoing (limited, in the case of legal expenses, to one counsel to the Indemnified
Persons taken as a whole and, if reasonably necessary, one local counsel in each relevant material jurisdiction and, in the case
of a conflict of interest, one additional counsel (and one additional counsel in each relevant material jurisdiction)

    	10

    	

    

to each group of affected Indemnified
Persons similarly situated, taken as a whole; provided that the foregoing indemnity will not, as to any Indemnified Person,
apply to losses, claims, damages, liabilities or related expenses (a) to the extent they have been determined in a final, non-appealable
judgment of a court of competent jurisdiction to have resulted primarily from the willful misconduct, bad faith or gross negligence
of such Indemnified Person, or material breach by such Indemnified Person of its obligations under this Commitment Letter or the
Loan Documents, or (b) that have resulted from any dispute solely among the Commitment Parties not arising from any act or omission
by the Borrower, the Target or their respective affiliates, other than any proceeding against an Indemnified Person in its capacity
or fulfilling its role as an administrative agent, arranger or other agent or any similar role under the Facilities or in respect
of the Specified Amendment, provided further that such Indemnified Person shall promptly repay to you all expense
reimbursements previously made pursuant to this paragraph to the extent that such Indemnified Person is finally determined by a
court of competent jurisdiction not to be entitled to indemnification hereunder as contemplated by the preceding proviso of this
paragraph. Notwithstanding any other provision of this Commitment Letter, no Indemnified Person shall be liable for (i) any damages
arising from the use by others of information or other materials obtained through electronic, telecommunications or other information
transmission systems, except to the extent such damages have been determined in a final, non-appealable judgment of a court of
competent jurisdiction to result from the willful misconduct, bad faith or gross negligence of such Indemnified Person, or (ii)
any special, indirect, consequential or punitive damages in connection with its activities related to this Commitment Letter, the
Specified Amendment, the Facilities or the use of proceeds thereunder.

 

You shall not be
liable for any settlement of any Proceedings effected without your prior written consent (which consent shall not be unreasonably
conditioned, withheld or delayed), but if settled with your prior written consent or if there is a judgment by a court of competent
jurisdiction in any such Proceedings, you agree to indemnify and hold harmless each Indemnified Person from and against any and
all losses, claims, damages, liabilities and expenses by reason of such settlement or judgment in accordance with the preceding
paragraph. You shall not, without the prior written consent of an Indemnified Person (which consent shall not be unreasonably conditioned,
withheld or delayed), effect any settlement or consent to the entry of any judgment of any pending or threatened Proceedings in
respect of which indemnity could have been sought hereunder by such Indemnified Person unless such settlement (i) includes an unconditional
release of such Indemnified Person in form and substance satisfactory to such Indemnified Person from all liability on claims that
are the subject matter of such Proceedings, (ii) does not include any statement as to or any admission of fault, culpability or
a failure to act by or on behalf of any Indemnified Person and (iii) contains customary confidentiality and non-disparagement provisions.
Except to the extent arising from your indemnification and expense reimbursement obligations under this Commitment Letter, the
Loan Documents or any other written agreement to which any such person is a party, in no event shall you, the Target and your and
its respective subsidiaries and affiliates be liable for special, indirect, consequential or punitive damages.

    	11

    	

    

9.     Confidentiality.

 

You agree that you will not
disclose, directly or indirectly, the Fee Letters and the contents thereof or this Commitment Letter and the Term Sheets and the
contents hereof and thereof, to any person without prior written approval of the Commitment Parties (not to be unreasonably conditioned,
withheld or delayed), except that you may disclose (a) this Commitment Letter, the Term Sheets, the Fee Letters and the contents
hereof and thereof (i) to your officers, directors, agents, employees, attorneys, accountants and advisors, in each case in connection
with the Transactions on a confidential and need-to-know basis, and (ii) pursuant to the order of any court or administrative agency
in any pending legal or administrative proceeding, or otherwise as required by applicable law, rule, regulation or compulsory legal
process or as requested by a governmental authority based on the reasonable advice of your legal counsel (in which case you agree
to provide prompt written notice thereof, such notice to be provided in advance to the extent permitted by applicable law), (b)
this Commitment Letter, the Term Sheets and the contents hereof and thereof and the Fee Letters and the contents thereof on a redacted
basis, with such redaction to be reasonably acceptable to the Commitment Parties, to the Target and its and its subsidiaries and
their respective officers, directors, agents, employees, attorneys, accountants and advisors, in each case in connection with the
Transactions and on a confidential and need-to-know basis, (c) the existence and contents of the Term Sheets to any rating agency
and Existing Lenders and potential Lenders in connection with the Transactions and (d) to the extent required by applicable law,
the existence and contents of this Commitment Letter and the Term Sheets in any public filing or prospectus or private placement
offering documents in connection with the Acquisition or the financing thereof. In addition you may disclose (i) the aggregate
amount of fees and other compensation under the Fee Letters (but without disclosing any specific fees, flex or other economic terms
set forth therein) aggregated with the other fees and compensation for the Transactions as part of projections, pro forma information
or generic disclosure of aggregate sources and uses related to the Transactions in any syndication of a Facility or in any prospectus
or offering memorandum related to the Notes or any other securities issued in lieu of any Facility or in any filings with (including
documents furnished to) the Securities Exchange Commission to the extent required by law or regulation, in each case to the extent
customary, and (ii) the Fee Letters and the contents thereof on a confidential basis after the Closing Date to the Borrower’s
auditors for customary accounting purposes, including accounting for deferred financing costs.

 

Notwithstanding anything herein
to the contrary, you (and any employee, representative or other agent of yours) may disclose to any and all persons, without limitation
of any kind, the tax treatment and tax structure of the transactions contemplated by this Commitment Letter and the Fee Letters
and all materials of any kind (including opinions or other tax analyses) that are provided to it relating to such tax treatment
and tax structure, except that (i) tax treatment and tax structure shall not include the identity of any existing or future party
(or any affiliate of such party) to this Commitment Letter or any Fee Letter and (ii) no party shall disclose any information relating
to such tax treatment and tax structure to the extent nondisclosure is reasonably necessary in order to comply with applicable
securities laws. For this purpose, the tax treatment of the transactions contemplated by this Commitment Letter and the Fee Letters
is the purported or claimed U.S. Federal income tax treatment of such

    	12

    	

    

transactions and the tax structure
of such transactions is any fact that may be relevant to understanding the purported or claimed U.S. Federal income tax treatment
of such transactions.

 

We shall use all material non-public
information received by us in connection with the Acquisition and the other transactions contemplated by this Commitment Letter
solely for the purposes of providing the services that are the subject of this Commitment Letter and shall treat confidentially
all such information, and shall not disclose such information to any third party or circulate or refer publicly to such information;
provided, however, that nothing herein shall prevent us from disclosing any such information (a) to rating agencies
on a confidential basis, (b) to any Existing Lenders, Lenders or participants, prospective Lenders or participants or any direct
or indirect contractual counterparties (or prospective counterparties) to any swap or derivative transaction relating to you or
the other Loan Parties’ and your or their obligations under the Existing Credit Facilities or the Facilities, (c) in any
legal, judicial or administrative proceeding or other compulsory process or otherwise as required by applicable law or regulations
(in which case we agree to, except with respect to any audit or examination conducted by bank accountants or any governmental bank
regulatory authority exercising examination or regulatory authority, promptly notify you, such notice to be provided in advance
to the extent permitted by applicable law), (d) upon the request or demand of any regulatory authority having or purporting to
have jurisdiction over us or our affiliates (in which case we agree to, except with respect to any audit or examination conducted
by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority, promptly notify
you to the extent lawfully permitted to do so), (e) to our officers, directors, agents, employees, attorneys, accountants and advisors
(collectively, “Representatives”) who need to know such information, are informed of the confidential nature
of such information and are or have been advised of their obligation to keep information of this type confidential, (f) to any
of our respective affiliates and their respective Representatives who need to know such information, are informed of the confidential
nature of such information and are or have been advised of their obligation to keep information of this type confidential (provided
that we shall be responsible for our affiliates’ compliance with this paragraph), solely in connection with the Acquisition
and the other transactions contemplated by this Commitment Letter, (g) to the extent any such information becomes publicly available
other than by reason of disclosure by us, our affiliates or Representatives in breach of this Commitment Letter, or to the extent
any such information is developed independently by us as evidenced by our written records and without the use of any confidential
information, (h) to the extent such information was already in our possession as evidenced by our written records prior to any
duty or other undertaking of confidentiality entered into in connection with the Transactions, or otherwise, (i) for purposes of
establishing a “due diligence” defense or in connection with the exercise of any rights or remedies and (j) to the
extent that you have consented in writing prior to such disclosure; provided that the disclosure of any such information
to any Existing Lenders, any Lenders or prospective Lenders, participants or prospective participants or derivative counterparties
or prospective derivative counterparties referred to above shall be made subject to the acknowledgment and acceptance by such Existing
Lender, Lender or prospective Lender, participant or prospective participant or derivative counterparty or prospective derivative
counterparty that such information is being disseminated on a confidential basis (on substantially the terms set forth in this
paragraph or as is otherwise reasonably acceptable to you and us, including, without limitation, as set forth in the Existing Credit
Facility or as agreed in any confidential information memorandum or other marketing

    	13

    	

    

materials) in accordance with
our standard syndication processes or customary market standards for dissemination of such type of information. In addition, each
Commitment Party may disclose the existence of the Facilities and the information about the Facilities and the Specified Amendment
to market data collectors, similar services providers to the lending industry, and service providers to the Commitment Parties
in connection with the administration and management of the Facilities or the Specified Amendment. Subject to the termination provisions
hereof, our obligations under this paragraph shall automatically expire upon the earlier of execution and delivery of the Loan
Documents and the first anniversary of the date hereof. For the avoidance of doubt, in no event shall any disclosure of such information
referred to above be made to any Disqualified Lender.

 

In consultation with you, any
of the Commitment Parties may place advertisements in financial and other newspapers and periodicals or on a home page or similar
place for dissemination of information on the Internet as it may choose, and circulate similar promotional materials, in the form
of a “tombstone” or otherwise describing the names of you, the Target and your and its affiliates (or any of them),
and the amount, type and closing date of the Facilities or the Specified Amendment, all at such Commitment Party’s expense.

 

You acknowledge that each Commitment
Party and its affiliates may be providing debt financing, equity capital or other services (including, without limitation, financial
advisory services) to other companies in respect of which you may have conflicting interests regarding the transactions described
herein and otherwise. The Commitment Parties and their respective affiliates will not use confidential information obtained from
you by virtue of the transactions contemplated by this Commitment Letter or any of their other relationships with you in connection
with the performance by them and their affiliates of services for other companies, and the Commitment Parties and their respective
affiliates will not furnish any such information to such other companies. By the same token, we will not make available to you
confidential information that we have obtained or may obtain from any other customer. You also acknowledge that no Commitment Party,
nor any of its affiliates, has any obligation to use in connection with the transactions contemplated by this Commitment Letter,
or to furnish to you, the Target or your or its subsidiaries, confidential information obtained by such Commitment Party and its
affiliates from other companies.

 

In connection with all aspects
of each transaction contemplated by this Commitment Letter, you acknowledge and agree, and acknowledge your affiliates’ understanding,
that: (i) the Facilities, the Specified Amendment and any related arranging or other services described in this Commitment Letter
is an arm’s-length commercial transaction between you and your affiliates, on the one hand, and the Commitment Parties, on
the other hand, (ii) the Commitment Parties have not provided any legal, accounting, regulatory or tax advice with respect to any
of the transactions contemplated hereby and you have consulted your own legal, accounting, regulatory and tax advisors to the extent
you have deemed appropriate, (iii) you are capable of evaluating, and understand and accept, the terms, risks and conditions of
the transactions contemplated hereby, (iv) in connection with the financing transactions contemplated hereby, each of the Commitment
Parties has been, is and will be acting solely as a principal and has not been, is not and will not be acting as an advisor, agent
or fiduciary for you, the Target or any of your or its affiliates, stockholders, creditors or employees or any other

    	14

    	

    

person, (v) the Commitment Parties
have not assumed and will not be deemed to assume an advisory, agency or fiduciary responsibility in your or your affiliates’
favor with respect to any of the financing transactions contemplated hereby (irrespective of whether any Commitment Party has advised,
is currently advising or will advise you, your equityholders or affiliates on other matters), and the Commitment Parties have no
obligation to you or your affiliates with respect to the financing transactions contemplated hereby except those obligations expressly
set forth in this Commitment Letter and the Engagement Letter and (vi) the Commitment Parties and their respective affiliates may
be engaged in a broad range of transactions that involve interests that differ from yours and those of your affiliates, and the
Commitment Parties have no obligation to disclose any of such interests to you or your affiliates. You hereby agree that you will
not assert any claim against the Commitment Parties based upon any breach or alleged breach of agency or fiduciary duty in connection
with any aspect of any financing transaction contemplated by this Commitment Letter. No Commitment Party has provided any legal,
accounting, regulatory or tax advice with respect to the Transactions and the other transactions contemplated by this Commitment
Letter and the Term Sheets and you have consulted with your own legal, accounting, regulatory and tax advisors to the extent you
have deemed it appropriate to do so.

 

As you know, Goldman, Sachs
& Co. has been retained by you (or one of your affiliates) as financial advisor (in such capacity, the “Financial
Advisor”) in connection with the Acquisition. The parties hereto agree to such retention, and further agree not to assert
any claim you might allege based on any actual or potential conflicts of interest that might be asserted to arise or result from
the engagement of the Financial Advisor, on the one hand, and Goldman, Sachs & Co. and its affiliates’ relationships
with you as described and referred to herein, on the other.

 

10.   Termination.

 

Our commitments and undertakings
hereunder shall terminate in their entirety automatically without further notice or action by us on the first to occur of (a) the
date which is five (5) business days after July 5, 2017; provided that in the event that the “End Date” under
the Acquisition Agreement shall have been extended to a later date pursuant to the provisos to Section 8.01(b)(i) thereof, the
date in this clause (a) shall be extended to such later date (but, in any event, no later than October 5, 2017), (b) the date of
the closing of the Acquisition, effective immediately following such closing, with or without the use of any portion of the Facilities,
and (c) the termination of the Acquisition Agreement in accordance with the terms thereof (such earliest date, the “Termination
Date”). Notwithstanding the foregoing, upon the effectiveness of the Specified Amendment, the commitments and any other
obligations of the Commitment Parties in respect of the Backstop Facility or the Specified Amendment (or any part thereof) shall
be terminated and have no further force or effect without any further action by the Commitment Parties or you.

 

Notwithstanding anything in
this Section 10 to the contrary, the termination of any commitment pursuant to this Section 10 does not prejudice your or our rights
and remedies in respect of any breach of this Commitment Letter that occurred prior to such termination.

    	15

    	

    

The Fee Letters and the compensation,
reimbursement, indemnification, syndication, information, jurisdiction, absence of agency or fiduciary relationship, conflicts
of interest, governing law, venue, waiver of jury trial and confidentiality provisions contained herein shall remain in full force
and effect regardless of whether the Loan Documents shall be executed and delivered and notwithstanding the termination of this
Commitment Letter or any Lender’s commitments hereunder; provided that your obligations under this Commitment Letter
(other than your obligations with respect to confidentiality, compensation, jurisdiction, waiver of jury trial, governing law,
venue, absence of agency or fiduciary relationship, conflicts of interest, information and assistance to be provided in connection
with the syndication of the Facilities) shall automatically terminate and be superseded to the extent of any corresponding provisions
of the Loan Documents covering substantially the same subject matter upon the execution and delivery thereof, and you shall automatically
be released from all liability hereunder in connection therewith at such time.

 

11.   Miscellaneous.

 

This Commitment Letter and the commitments
and undertakings hereunder shall not be assignable by any party hereto without the prior written consent of each other party hereto,
and any attempted assignment without such consent shall be void and of no effect; provided, however, each Commitment
Party may assign its commitment and other rights and obligations hereunder, in whole or in part, (a) to any of its affiliates (including,
for the avoidance of doubt, assignments between JPMorgan Chase Bank and JPMorgan Securities or Goldman Sachs), (b) as provided
in Section 2 hereof, to any Additional Arranger or its affiliates and (c) subject to Section 2 and 3 hereof, in connection with
the syndication of the Facilities or the arrangement of the Specified Amendment; provided that, except for (i) assignments
between JPMorgan Chase Bank and JPMorgan Securities or Goldman Sachs and Goldman Sachs Lending Partners LLC and (ii) assignments
to any Additional Arranger, such Commitment Party shall not be released from the portion of its commitment hereunder so assigned
to the extent such assignee fails to fund the portion of the commitment assigned to it on the Closing Date notwithstanding the
satisfaction of the conditions to such funding set forth herein. Any assignment in violation of the foregoing shall be null and
void. This Commitment Letter is intended to be solely for the benefit of the parties hereto and the Indemnified Persons and is
not intended to confer any benefits upon, or create any rights in favor of or be enforceable by, any person other than the parties
hereto and the Indemnified Persons, except that the Commitment Parties may perform the duties and activities described hereunder
through any of their respective affiliates or branches and the provisions of Section 9 shall apply with equal force and effect
to any of such affiliates or branches so performing any such duties or activities.

 

12.   Governing
Law; Waiver of Jury Trial; etc.

 

This Commitment Letter and
the Fee Letters shall be governed by and construed in accordance with the laws of the State of New York; provided that the
laws of the State of Delaware shall govern in determining (i) whether the Acquisition has been consummated in accordance with the
terms of the Acquisition Agreement, (ii) whether a Company Material Adverse Effect (as defined in the Acquisition Agreement) has
occurred

    	16

    	

    

and (iii) accuracy of any
Acquisition Agreement Representations. Each of the parties hereto waives all right to trial by jury in any action, proceeding or
counterclaim (whether based upon contract, tort or otherwise) related to or arising out of this Commitment Letter, the Fee Letters,
each element of the Transactions or the performance by us or any of our affiliates of the services contemplated hereby. In addition,
with respect to any action, proceeding or counterclaim arising out of or relating to this Commitment Letter, the Fee Letters, the
Transactions or the performance by us or any of our affiliates of the services contemplated hereby, the parties hereto hereby irrevocably:
(a) submit to the exclusive jurisdiction of any New York State or Federal court sitting in the Borough of Manhattan in the City
of New York, New York; (b) agree that, subject to the final sentence of this paragraph, all claims with respect to such action
or proceeding may be heard and determined exclusively in such New York State or Federal court; (c) waive the defense of any inconvenient
forum to such New York State or Federal court; (d) agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in another jurisdiction by suit on the judgment or in any other manner provided by law; and (e) consent to
service of process by mailing or delivering a copy of such process to such party at its address set forth in Section 15
hereof and agree that such service shall be effective when sent or delivered. Nothing in this Commitment Letter shall affect any
right that any Commitment Party or any of its affiliates may otherwise have to bring any action or proceeding relating to this
Commitment Letter and the Transactions against you or your properties in the courts of any jurisdiction.

 

13.   Amendments;
Counterparts; etc.

 

No amendment or waiver of any
provision hereof (including the Term Sheets) or of a Fee Letter shall be effective unless in writing and signed by each of the
parties hereto or thereto and then only in the specific instance and for the specific purpose for which given. This Commitment
Letter (including the Term Sheets) and the Fee Letters are the only agreements among the parties hereto with respect to the matters
contemplated hereby and thereby and set forth the entire understanding of the parties hereto with respect thereto. This Commitment
Letter may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when
so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery
of an executed counterpart of a signature page of this Commitment Letter by facsimile transmission (or in pdf or similar format
by electronic mail) shall be effective as delivery of a manually executed counterpart of this Commitment Letter.

 

14.   PATRIOT Act Notification.

 

We hereby notify you that pursuant
to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (as the same may be
extended and in effect from time to time, the “PATRIOT Act”), each Commitment Party is required to obtain, verify
and record information that identifies the Borrower and the Guarantors, which information includes the name, address, tax identification
number and other information regarding the Borrower and the Guarantors that will allow the Commitment Parties to identify the Borrower
and the Guarantors in accordance with the PATRIOT Act. This notice is given in

    	17

    	

    

accordance with the requirements
of the PATRIOT Act and is effective as to each Commitment Party and each Lender. You hereby acknowledge and agree that the Commitment
Parties shall be permitted to share any or all such information with the Lenders.

 

15.   Notices.

 

Any notice given pursuant to
this Commitment Letter shall be mailed or hand delivered in writing, if to (a) you, at your address set forth on page one hereof
and (b) JPMorgan Chase Bank or Goldman Sachs at their respective addresses set forth on page one hereof.

 

Each of the parties hereto agrees
that this Commitment Letter and the Fee Letters are binding and enforceable agreements with respect to the subject matter contained
herein and therein, including an agreement to negotiate in good faith the Facilities and the Specified Amendment by the parties
hereto in a manner consistent with this Commitment Letter, it being acknowledged and agreed that the commitments provided hereunder
by the Commitment Parties are subject only to the conditions precedent set forth in Exhibit H hereto.

 

If the foregoing proposal is
acceptable to you, please so confirm by signing and returning to us executed counterparts of this Commitment Letter and the Fee
Letters. Unless we receive your executed counterparts hereof and thereof by 11:59 p.m., New York City time, on January 6, 2017,
our offer hereunder will automatically expire at such time without further action or notice.

 

[Signature pages follow.]

    	18

    	

    

We are pleased to have this
opportunity and we look forward to working with you on this transaction.

 

	 	Very truly yours,
	 	 
	 	JPMORGAN CHASE BANK, N.A.
	 	 
	 	By:	/s/ D. Scott Farquhar
	 	 	Name:	D. Scott Farquhar
	 	 	Title:	Executive Director
	 	 	 	 

	 	GOLDMAN SACHS BANK USA
	 	 
	 	By:	/s/ Charles D. Johnston
	 	 	Name:	Charles D. Johnston
	 	 	Title:	Director

 

[Signature Page to Commitment Letter]

    	 

    	

    

Accepted and agreed to as of the date first written above:

 

GARTNER, INC.

 

	By:	/s/ Craig Safian	 
	 	Name: Craig Safian
	 	Title: Chief Financial Officer

 

[Signature Page to Commitment Letter]

    	 

    	

    

	CONFIDENTIAL	EXHIBIT A

 

Project Cobra

Transaction Description

 

Capitalized terms used but not
defined in this Exhibit A shall have the meanings set forth in the Commitment Letter to which this Exhibit A is attached
or the other Exhibits to the Commitment Letter.

 

Pursuant to the terms of that
certain Agreement and Plan of Merger dated as of the date of the Commitment Letter, among the Borrower, a certain newly formed
subsidiary of the Borrower party thereto and the Target (together with all exhibits, schedules and disclosure letters thereto,
collectively, the “Acquisition Agreement”), the Borrower will acquire the Target (the “Acquisition”).

 

In connection with the Acquisition,
it is intended that:

 

(a)     (i) The Borrower’s
existing revolving credit facility (the “Existing RC Facility”) and existing term loan A facility (the “Existing
TLA Facility” and, together with the Existing RC Facility, the “Existing Credit Facilities”) will
be amended pursuant to the Specified Amendment as described in Exhibit B to the Commitment Letter and the Existing RC Facility
drawn down in an amount to be determined by the Borrower or (ii) the Borrower will obtain a senior secured revolving credit facility
(the “RC Backstop Facility”) and a senior secured term loan B facility (the “TLB Backstop Facility”
and, together with the RC Backstop Facility, the “Backstop Facilities”) to refinance all the outstanding commitments
and loans under the Existing Credit Facility, which will be available to be drawn at the Closing, subject to the satisfaction or
waiver of the conditions set forth in the Backstop Facilities Term Sheet.

 

(b)     The Borrower will obtain
a seven-year senior secured term loan B facility (the “Term Loan B Facility,” together with the Existing Credit
Facilities or the Backstop Facilities, as applicable, the “Senior Secured Facilities”) in an aggregate principal
amount of $1,375 million, which Term Loan B Facility may take the form of an incremental term loan incurred under the Existing
Credit Agreement.

 

(c)     The Borrower will obtain
a 364-day senior unsecured bridge facility (the “364-day Bridge Facility”) in an aggregate principal amount
of $300 million.

 

(d)     The Borrower intends
to (i) issue and sell senior unsecured notes providing for gross proceeds of up to $600 million on or prior to the Closing Date
(the “Notes”) pursuant to a Rule 144A (with or without registration rights) or other private placement; or (ii) to
the extent that all or a portion of such offering of Notes providing such amount of gross proceeds has not been entered into on
or prior to the Closing Date, obtain up to $600 million in the aggregate (less the amount of any gross proceeds from the issuance
of Notes for purposes of consummating the Acquisition) under a senior unsecured bridge loan facility described in Exhibit F
(the “HY Bridge Facility” and, together with the Backstop Facilities, the Term Loan B Facility and the 364-day
Bridge Facility, the “Facilities”), in each case, the proceeds of which will be used for the purpose of consummating
the Acquisition and the Debt Repayment (as defined below).

    	A-1

    	

    

(e)     The following indebtedness
of the Target and its subsidiaries, in each case as amended, will be repaid or otherwise satisfied and discharged, with all commitments
thereunder terminated and all security and guarantees in respect thereof (if any) discharged and released (the “Debt Repayment”):

 

(1)     Credit Agreement, dated
as of July 2, 2012, among the Target, Bank of America, N.A., as administrative agent, collateral agent, swingline lender and L/C
issuer thereunder and the lenders party thereto, as amended, restated, amended and restated, supplemented or otherwise modified
from time to time prior to the date hereof; and

 

(2)     Indenture, dated as
of June 9, 2015, among the Target, each of the Guarantors party thereto and Wilmington Trust, National Association, relating to
the 5.625% Senior Notes due 2023.

 

The proceeds of the Term Loan
B Facility, 364-day Bridge Facility, HY Bridge Facility and the draw on the Existing RC Facility or the RC Backstop Facility, as
applicable will be applied to the Debt Repayment and to pay a portion of the Cash Consideration (as defined in the Acquisition
Agreement) and all or a portion of the fees and expenses incurred in connection with the Transactions (such fees and expenses,
the “Transaction Costs”) and, if the Specified Amendment is not obtained on or prior to the Closing Date, the
proceeds of loans under the Backstop Facilities on the Closing Date may be applied to repay loans under the Existing Credit Facilities
and to pay the Transaction Costs and letters of credit under the Backstop Facilities may be used to replace, backstop or, subject
to the consent of the issuer thereof, “grandfather” any letters of credit.

 

The transactions described above
are collectively referred to herein as the “Transactions” and, the date of the consummation of the Acquisition,
the “Closing Date.”

    	A-2

    	

    

	CONFIDENTIAL	EXHIBIT B

 

Project Cobra

Summary of Specified Amendment

 

The term “Specified
Amendment” refers to the following amendments to the Credit Agreement, dated as of June 17, 2016, by and among Gartner,
Inc., JPMorgan Chase Bank N.A., as administrative agent (in such capacity, the “Existing Credit Facilities Administrative
Agent”), and the lenders party thereto (the “Existing Credit Agreement”), in each case, in the form
to be mutually agreed by the Borrower and the Amendment Lead Arrangers:

 

		(a)	Negative Covenants:

 

		(i)	Section 7.1(a) shall be amended to prohibit the Consolidated Leverage Ratio (as defined in the
Existing Credit Agreement) from exceeding (1) 5.25 to 1.00, net of cash up to 50% of Consolidated EBITDA, for the first six fiscal
quarters following the Closing Date and (2) thereafter, without the netting of any cash, from exceeding (x) 4.50 to 1.00 or (y)
4.75 to 1.00 for any fiscal quarter during any Acquisition Step-Up Period (as defined in the Existing Credit Agreement).

 

		(ii)	Section 7.1(b) shall be amended to prohibit the Consolidated Secured Leverage Ratio (as defined
in the Existing Credit Agreement) from exceeding (1) 4.25 to 1.00, net of cash up to 50% of Consolidated EBITDA, for the first
six fiscal quarters following the Closing Date and (2) thereafter, without the netting of any cash, from exceeding (x) 3.50 to
1.00 or (y) 3.75 to 1.00 for any fiscal quarter during any Acquisition Step-Up Period (as defined in the Existing Credit Agreement).

 

		(iii)	Sections 7.2 and 7.3 shall be amended to permit the pre-existing debt of the Target and its subsidiaries
(other than any indebtedness required to be repaid or otherwise discharged and satisfied as part of the Debt Repayment) permitted
under the Acquisition Agreement to be outstanding on the Closing Date.

 

		(iv)	Section 7.2(o) (Permitted Subordinated Debt and Permitted Senior Unsecured Debt) shall be amended
to require pro forma compliance with a Consolidated Leverage Ratio of not more than 5.25 to 1.00 (in addition to pro forma compliance
with the covenants set forth in Sections 7.1(b) and (c)).

 

		(v)	A Section 7.2(u) shall be added to permit the incurrence of Indebtedness up to an aggregate principal
amount of $25,000,000.

    	B-1

    	

    

		(vi)	Section 7.6(a)(iv) shall be amended to limit the payment of cash dividends to holders of Permitted
Preferred Stock thereunder to no more than $50,000,000.

 

		(vii)	Section 7.6(a)(xi)(ii)(y) and (b)(iii)(y) shall each be amended to require pro forma compliance
with a (x) Consolidated Leverage Ratio of not more than 4.25 to 1.00, (y) Consolidated Secured Leverage Ratio of not more than
3.25 to 1.00 and (z) Consolidated Interest Expense Ratio of not less than 3.25 to 1.00.

 

		(viii)	Section 7.8(i)(i) (acquisitions of assets or capital stock) shall be amended to require pro forma
compliance with a (x) Consolidated Leverage Ratio of not more than 4.50 to 1.00, (y) Consolidated Secured Leverage Ratio of not
more than 3.50 to 1.00 and (z) Consolidated Interest Expense Ratio of not less than 3.25 to 1.00.

 

		(b)	Definitions:

 

		(i)	The definition of “Consolidated EBITDA” shall be amended to provide for add backs for
costs and expenses relating to the Transactions and pro forma cost savings based on actions taken or expected to be taken within
24 months of the closing of the Transactions (but subject to a cap of 20% as set forth in the Existing Credit Agreement).

 

		(ii)	The definition of “Consolidated Net Income” shall be amended to provide that any subsidiary
or line of business acquired as part of the Transactions that is or becomes a discontinued operation because it is being held for
sale shall not be excluded from Consolidated Net Income (it being understood that upon the consummation of the actual sale of such
subsidiary or line of business, the results thereof shall be excluded from Consolidated Net Income at the beginning of the applicable
period and that, at the time of any calculation of Consolidated Net Income, any debt prepayments expected to be made within 10
business days of consummation of the sale of such asset shall be reflected on a pro forma basis for the purpose of any compliance
or ratio test as if such prepayment had occurred at the beginning of the appropriate period (it being understood that if such prepayment
is not made within such 10 business day period, Consolidated Net Income shall be recalculated at such time without giving effect
to such prepayment).

 

		(iii)	The definition of “L/C Commitment” shall be amended to provide for an aggregate commitment
of $75,000,000.

    	B-2

    	

    

		(iv)	The definition of “Applicable Margin” shall be amended as set out in Exhibit C
hereto under the heading “Interest Rates.”

 

		(v)	The definition of “Permitted Acquisition” shall be amended to include a provision permitting
the consummation of the Acquisition as contemplated by the Acquisition Agreement.

 

		(vi)	The definition of “Permitted Senior Unsecured Notes” shall be amended by deleting the
words “in an aggregate principal amount not exceeding $500,000,000” and replacing them with “to the extent the
proceeds of which are used to finance the Acquisition”.

 

		(c)	Other:

 

		(i)	Section 2.1(b)(i) shall be amended to permit establishment of additional incremental revolving
commitments in an aggregate amount of up to $750 million and Section 2(b)(i)(A) shall be amended to increase the incremental pro
forma compliance to a Consolidated Secured Leverage Ratio not exceeding 3.50 to 1.00.

 

		(ii)	Section 2.1(b) shall be amended to permit incurrence of the Term Loan B Facility as an incremental
facility under the Existing Credit Facility, and to permit amendment to the voting, mandatory prepayment and other terms to reflect
the terms set out in Exhibit D.

 

		(iii)	Section 5.2 shall be amended so that the only conditions precedent to the extensions of credit
by the Lenders to the Transactions shall be those set out in Exhibit H hereto, subject to the Limited Conditionality Provisions;
provided that such amendment and the Limited Conditionality Provisions shall only apply to drawings under the Existing RC
Facility to the extent that the Specified Amendment has been successfully obtained and each other Facility funded on the Closing
Date and the Notes, if applicable, have been fully drawn or issued, as the case may be, and applied to the Transaction Costs.

 

		(iv)	The Existing Credit Agreement shall be amended as follows to permit each of the Term Loan B Facility,
the 364-day Bridge Facility, the HY Bridge Facility and the Notes:

 

		1.	Section 7.2 shall be amended to include exceptions to permit the incurrence of the Term Loan B
Facility, the 364-day Facility, the HY Bridge Facility and any Indebtedness issued to replace all or a portion of the commitments
thereunder, including the Notes, and in each case any refinancing thereof.

    	B-3

    	

    

		2.	Section 7.3 shall be amended to permit the incurrence of Liens in respect of the Term Loan B Facility
and any refinancing thereof.

 

		3.	Sections 7.2 and 7.3 shall be amended to permit the incurrence of the Notes and/or the Term Loan
B Facility prior to the Closing Date for the sole purpose of financing the Transaction on the Closing Date and the deposit of the
proceeds of the Notes and/or the Term Loan B Facility into escrow (and any related guarantees of interest payments related thereto
secured on a pari passu basis with the Existing Credit Facilities) or for such proceeds to be held by the Borrower pending the
Closing Date; provided that in the event that the aggregate proceeds of such incurrence exceed $600,000,000, the Borrower
shall be required to either (i) reduce the commitments under any committed source of financing intended to finance the Transactions,
(ii) reduce the anticipated drawing amount under the Existing RC Facility or the RC Backstop Facility intended to pay Transaction
Costs on the Closing Date or (iii) repay amounts outstanding under the Existing RC Facility, in each case, by an amount equal to
such excess.

 

		4.	Section 7.5 shall be amended to permit the disposition of any non-core assets acquired as part
of the Transactions.

 

		5.	Section 7.6 shall be amended to (i) limit the amount of all Restricted Payments permitted to be
made under the Credit Agreement while the 364-day Bridge Facility is outstanding to $50,000,000 and (ii) exclude the 364-day Bridge
Facility and the HY Bridge Facility from the restrictions on Restricted Debt Payments (other than repayments of the 364-day Bridge
Facility directly funded with the proceeds of any senior secured indebtedness on the date of the incurrence of such senior secured
indebtedness, which shall remain restricted under Section 7.6).

 

		6.	Section 7.8 will be amended to add a new clause permitting the consummation of the transaction
previously identified to us.

 

		7.	Sections 7.13 and 7.14 shall be amended to permit any restrictions under the Facilities.

 

		(v)	Each of the dollar-based baskets and thresholds set out in Sections 7 and 8 (other than those baskets
otherwise addressed in this Exhibit B) shall be increased by 50%.

    	B-4

    	

    

		(vi)	Additional baskets shall be added to Sections 7.6(a), 7.6(b) and 7.8 permitting Restricted Equity
Payments, Restricted Debt Payments and Investments, respectively, up to the “Available Amount”, subject in each case
to compliance with a Consolidated Leverage Ratio of not more than 4.75 to 1.00, with the “Available Amount” to include
(i) a $100,000,000 “starter basket” and (ii) additional amounts to be based on the unapplied portion of Excess Cash
Flow (to be defined as mutually agreed and with the deductions described under “Mandatory Prepayments” in Exhibit
C below).

 

		(vii)	Section 5.2(c) of the Guarantee and Collateral Agreement, dated as of June 17, 2016, by Gartner,
Inc. and certain of its subsidiaries in favor of JPMorgan Chase Bank N.A., as administrative agent shall be amended to add a proviso
at the end of the sentence that reads “; provided that no Grantor shall be required to execute any deposit account
control agreement or securities account control agreement in favor of the Administrative Agent”.

    	B-5

    	

    

	CONFIDENTIAL	EXHIBIT
    C

 

Project Cobra

Senior Secured Backstop Facilities

Summary of Principal Terms and Conditions

 

Capitalized terms used
but not defined in this Exhibit C shall have the meanings set forth in the Commitment Letter to which this Exhibit C
is attached or the other Exhibits to the Commitment Letter.

 

	Borrower:	 	Gartner,
    Inc., a Delaware corporation (the “Borrower”).
	 	 	 
	Lead Arrangers
    and Bookrunners:	 	JPMorgan Chase Bank,
    N.A. (“JPMorgan Chase Bank”) and each other financial institution appointed as a lead arranger and/or bookrunner
    pursuant to the terms of the Commitment Letter (collectively, the “Backstop Lead Arrangers”).
	 	 	 
	Administrative
    Agent:	 	JPMorgan Chase Bank
    will act as sole administrative agent (in such capacity, the “Backstop Administrative Agent”).
	 	 	 
	Transactions:	 	As
    described in Exhibit A to the Commitment Letter.
	 	 	 
	Lenders:	 	JPMorgan Chase Bank
    (or one of its affiliates) and a syndicate of financial institutions and other lenders (the “Backstop Lenders”)
    arranged by the Backstop Lead Arrangers as contemplated by the Commitment Letter.
	 	 	 
	RC Backstop
    Facility:	 	If the Specified Amendment
        is not obtained on or prior to the Closing Date, the Backstop Lenders will provide a senior secured revolving credit facility
        in aggregate principal amount of $500 million (the “RC Backstop Facility”).

         

        Up to $75,000,000 of
        the RC Backstop Facility will be available in the form of standby letters of credit to be provided by the Commitment Parties
        (ratably in accordance with their commitments in respect of the RC Backstop Facility under the Commitment Letter) and/or
        other Backstop Lenders to be mutually agreed that consent to act in such capacity (with the amount of each such Backstop
        Lender’s commitment to issue letters of credit being as separately agreed by the Borrower and such Backstop Lender,
        and such commitment to reduce ratably the commitments of the Commitment Parties to issue letters of credit). The obligation
        of letter of credit issuers under the Backstop Facility to issue, extend, renew or amend any letter of credit shall be
        subject to the policies and procedures of such letter of credit issuer.

    	C-1

    	

    

	TLB
    Backstop Facility:	 	If
    the Specified Amendment is not obtained on or prior to the Closing Date, the Backstop Lenders will provide a senior secured
    term loan B credit facility in aggregate principal amount of $1.2 billion (the “TLB Backstop Facility”
    and together with the RC Backstop Facility, the “Backstop Facilities”).
	 	 	 
	Purpose:	 	The
    commitments under and the proceeds of the Backstop Facilities will be used to refinance the Existing Credit Facilities, finance
    the Acquisition, the Debt Repayment and the Transaction Costs.
	 	 	 
	Availability:	 	If
    the Specified Amendment is not obtained on or prior to the Closing Date, the full amount of the Backstop Facilities will be
    made available on the Closing Date to refinance amounts outstanding under the Existing Credit Facilities and for fees and
    costs in connection with the Transactions, and the Backstop Facilities will be available after the Closing Date to finance
    working capital and general corporate purposes.
	 	 	 
	Ranking:	 	The
    Backstop Facilities will rank pari passu with the Term Loan B Facility and other senior secured indebtedness
    of the Borrower.
	 	 	 
	Guarantees:	 	Substantially
    the same as and limited to those set forth in the Existing Credit Facility. The Target and each of its subsidiaries
    that would be required to guarantee the Existing Credit Facilities will, subject to the “Guarantee and Collateral Provisions”
    as set forth in the immediately succeeding paragraph, be required to become guarantors. The Borrower and the guarantors are
    collectively referred to as the “Loan Parties.”
	 	 	 
	Guarantee
    and Collateral Provisions:	 	Subject to the Backstop
    Documentation Principles and the Limited Conditionality Provisions, the Borrower’s obligations shall be secured by a
    perfected first priority security interest in all of the Borrower’s and Target’s tangible and intangible assets,
    subject to limitations and exclusions which shall be substantially the same as those set forth in the Existing Credit Facilities.
	 	 	 
	Maturity:	 	The RC Backstop Facility
    will mature on June 17, 2021. Loans under the TLB Backstop Facility will mature seven years after the Closing Date, and will
    be subject to amortization at the rate of 1.00% per annum with a bullet payment at the final  maturity thereof.
	 	 	 
	Interest
    Rate:	 	With respect to the
    TLB Backstop Facility, the Borrower may elect that the loans thereunder bear interest at a rate per annum equal to (a) the
    Base Rate (as defined in Exhibit D) plus 175.0 basis points or (b) the Adjusted LIBO Rate (as defined in Exhibit D)
    plus 275.0 basis points.

    	C-2

    	

    

	 	 	With respect
    to the loans and commitments under the RC Backstop Facility, the interest rates shall be in accordance with the below:
	 	 	 

	Leverage

    ˃ 5.00x

    ˃ 4.50x

    ˃ 4.00x

    ˃ 3.50x

    ˃ 2.75x

    ˃ 1.75x

    ˃ 0.75x

    ≤ 0.75x	Drawn
    (bps)

    L + 300.0

    L + 250.0

    L + 200.0

    L + 175.0

    L + 150.0

    L + 137.5

    L + 125.0

    L + 112.5	Undrawn
    (bps)

    50.0

    40.0

    35.0

    30.0

    25.0

    20.0

    17.5

    12.5

 

	Original
    Issue Discount:	 	The
    TLB Backstop Facility shall be subject to an original discount of 0.50%.
	 	 	 
	Letter
    of Credit Fees:	 	Subject
    to the Backstop Documentation Principles, substantially the same as and limited to those set forth in the Existing Credit
    Facilities.
	 	 	 
	Default
    Rate:	 	Subject
    to the Backstop Documentation Principles, substantially the same as and limited to those set forth in the Existing Credit
    Facilities.
	 	 	 
	Mandatory
    Prepayment:	 	Subject to the Backstop
        Documentation Principles, substantially the same as those set forth in the Existing Credit Facilities and including mandatory
        prepayments for the following:

         

        (a) with
        respect to the TLB Backstop Facility only, 100% of the net cash proceeds received by the Borrower or any of its restricted
        subsidiaries from any Asset Sale or Recovery Event (as defined in the Existing Credit Agreement) consummated after the
        Closing Date, subject to reinvestment rights and other limitations, provided that such mandatory prepayments shall
        be shared on a pro rata basis with the equivalent mandatory prepayment requirements under the Term Loan B Facility (whether
        or not documented as a Combined Term Facility (as defined below)).

         

        (b) 100%
        of the net cash proceeds received by the Borrower from any debt issuance (other than any indebtedness permitted to be
        incurred under the Existing Credit Agreement (as modified by the Specified Amendment) (“Permitted Debt”)
        and the Transactions described in Exhibit A) after the Closing Date; provided that (i) until the first anniversary
        of the Closing Date no such mandatory prepayments shall be required under this clause (b) with respect to the incurrence
        of unsecured debt until such amounts are applied in satisfaction of the

    	C-3

    	

    

	 	 	equivalent
        mandatory prepayment or commitment reduction requirements under the HY Bridge Facility (or the HY Bridge Facility is no
        longer outstanding), (ii) if the HY Bridge Facility is no longer outstanding or the equivalent mandatory prepayment or
        commitment reduction requirements with respect thereto have already been satisfied but the 364-day Bridge Facility is
        outstanding, the Borrower may, in its discretion, apply such proceeds in satisfaction of any equivalent mandatory prepayment
        or commitment reduction requirements under the 364-day Bridge Facility or to the TLB Backstop Facility pursuant this clause
        (b) (or any combination of the foregoing) and (iii) if such proceeds are applied to the TLB Backstop Facility pursuant
        to this clause (b), such mandatory prepayments shall be shared on a pro rata basis with the equivalent mandatory prepayment
        requirements under the Term Loan B Facility (whether or not documented as a Combined Term Facility).

         

        (c) With
        respect to the TLB Backstop Facility only, 50% of Excess Cash Flow, subject to (i) reduction to 25% upon the Consolidated
        Secured Leverage Ratio (as defined in the Existing Credit Agreement) being equal to or less than 3.00 to 1.00 and (ii)
        elimination upon the Consolidated Secured Leverage Ratio being equal to 2.50 to 1.00, payable within 10 business days
        after delivery of the annual audited financial statements (starting with the fiscal year ending December 31, 2018); provided that the amount of the prepayment otherwise required from Excess Cash Flow shall be reduced on a dollar for dollar
        basis by (x) the amount of voluntary prepayments of any long-term indebtedness, including the aggregate amount of any
        prepayment of the 364-day Bridge Facility and any permanent reductions of the Senior Secured Facility commitments during
        such fiscal year and, at the option of the Borrower, after year end and prior to the time such Excess Cash Flow Payment
        is due, (y) internally generated cash (to be defined to exclude the proceeds of financings other than revolver draws)
        used or contractually committed to be used within a time limit to be agreed for capital expenditures, Permitted Acquisitions
        (as defined in the Existing Credit Agreement) and other investments, and certain restricted payments, in each case, during
        such fiscal year and, at the option of the Borrower, after year end and prior to the time such Excess Cash Flow Payment
        is due and (z) to the extent such Excess Cash Flow is attributable to foreign subsidiaries, amounts that may not be repatriated
        and applied to prepayments without material adverse tax consequences for 

    	C-4

    	

    

	 	 	the Borrower;
        provided that such mandatory prepayments shall be shared on a pro rata basis with the equivalent mandatory prepayment
        requirements under the Term Loan B Facility (whether or not documented as a Combined Term Facility).

         

        Any mandatory prepayments required under this paragraph
        will be applied as directed by the Borrower.

	 	 	 
	Optional
    Prepayment:	 	Subject to the Backstop
        Documentation Principles, substantially the same as and limited to those set forth in the Existing Credit Facilities;
        provided that any voluntary prepayments of the TLB Backstop Facility made in the first six months following the
        Closing Date in the event of a Repricing Transaction will be subject to a 1.00% prepayment premium.

         

        “Repricing
        Transaction” means, in connection with a transaction the primary purpose of which is to prepay, refinance, substitute
        or replace the TLB Backstop Facility or to amend the TLB Backstop Facility to reduce the Yield, (a) the prepayment, refinancing,
        substitution or replacement of all or a portion of the TLB Backstop Facility with the incurrence of any long-term debt
        financing by the Borrower or any restricted subsidiaries having a Yield at the time of incurrence thereof that is less
        than the Yield of such TLB Backstop Facility at the time of such incurrence or (b) any amendment to the credit agreement
        that, directly or indirectly, reduces the Yield of the TLB Backstop Facility. No “Repricing Transaction” shall
        be deemed to occur in connection with any change of control, initial public offering or transformative investment or acquisition
        (each such term to be defined in a manner to be mutually agreed).

         

        “Yield”
        shall mean, with respect to any indebtedness, the yield thereon, as determined by the Borrower in good faith consistent
        with generally accepted financial practices, after giving effect to, among other factors, margin, interest rate floors,
        upfront or similar fees or original issue discount shared with all providers of such financing, with upfront fees and
        original issue discount being equated to interest margins based on an assumed four year life to maturity, but excluding
        the effect of any ticking, unused line, amendment, arrangement, structuring, syndication, commitment, underwriting or
        similar fees (regardless of whether paid, in whole or in part, to any or all lenders or holders or other fees not paid
        generally to all lenders or holders of indebtedness).

	 	 	 
	Documentation:	 	The definitive documentation
    for the Backstop Facilities (the “Backstop Documentation”) will be drafted by counsel to Borrower,

    	C-5

    	

    

	 	 	negotiated
    in good faith by Borrower and the Commitment Parties and will be based on the Existing Credit Agreement, as in effect on the
    date of the Commitment Letter but after giving effect to the Specified Amendment, and solely with such other modifications
    thereto as are required to reflect (a) the terms and conditions set forth in this Exhibit C, (b) scheduled exceptions
    to the representations and warranties to be subject to the reasonable approval of the Backstop Lead Arrangers, except with
    respect to any exceptions scheduled to Existing Credit Facilities or otherwise previously disclosed to the Commitment Parties
    and (c) modifications to the Existing Credit Facilities to account for changes in law or accounting standards or to cure mistakes
    or defects (it being understood that if a modification of any provision in the definitive documentation is proposed pursuant
    to this clause (c), but the Borrower and the Backstop Lead Arrangers fail to mutually agree on any modification of such provision
    in the requisite time period to allow effectiveness on the Closing Date, such provision shall be in the form of the corresponding
    provision of the Existing Credit Facilities). The Backstop Documentation shall contain only those conditions to borrowing,
    mandatory prepayments, representations and warranties, affirmative, negative and financial covenants and events of default
    set forth in this Exhibit C, which, subject to the preceding sentence, shall be substantially consistent with, but
    no less favorable to the Borrower in any respect than, the Existing Credit Facilities. The TLB Backstop Facility may be documented
    together with the Term Loan B Facility as a single senior secured term loan b facility with the terms described in this Exhibit
    C and Exhibit D, as applicable (such facility the “Combined Term Facility”).
    The principles set forth in this paragraph are referred to as the “Backstop Documentation Principles”.
	 	 	 
	Conditions
    Precedent to Closing Date Borrowing:	 	The
    availability of the borrowing under the Backstop Facilities on the Closing Date shall only be subject to the Limited Conditionality
    Provisions and the applicable conditions set forth in Exhibit H to the Commitment Letter.
	 	 	 
	Conditions
    Precedent to Borrowings after the Closing Date	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Representations
    and Warranties:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities, it being understood that the representations and warranties made on
    the Closing Date will cover the Target and its subsidiaries (in the case of “excluded subsidiaries” of the Target,
    only to the extent such representations and warranties cover the “excluded subsidiaries” of the Borrower) 

    	C-6

    	

    

	 	 	and
    the Acquisition and the other Transactions.
	 	 	 
	Affirmative
    Covenants:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities (as modifed by the Specified Amendment).
	 	 	 
	Negative
    and Financial Covenants:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions,
    substantially the same as and limited to those set forth in the Existing Credit Facilities (as modified by the Specified
    Amendment).
	 	 	 
	Events
    of Default:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Cost and
    Yield Protection:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Assignments
    and Participation:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Voting:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Expenses
    and Indemnification:	 	Subject
    to the Backstop Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Governing
    Law and Forum:	 	New
    York, including exclusive New York jurisdiction.
	 	 	 
	Counsel
    to Backstop Administrative Agent and Backstop Lead Arrangers:	 	Simpson
    Thacher & Bartlett LLP.
	 	 	 
	Counsel
    to Borrower:	 	Sullivan
    & Cromwell LLP.

    	C-7

    	

    

	CONFIDENTIAL	EXHIBIT D

 

Project Cobra

Term Loan B Facility

Summary of Principal Terms and Conditions

 

Capitalized terms
used but not defined in this Exhibit D shall have the meanings set forth in the Commitment Letter to which this Exhibit
D is attached or the other Exhibits to the Commitment Letter.

 

	Borrower:	 	Gartner,
    Inc., a Delaware corporation (the “Borrower”).
	 	 	 
	Lead Arrangers
    and Bookrunners:	 	JPMorgan Chase Bank,
    N.A. (“JPMorgan Chase Bank”), Goldman Sachs Bank USA (“Goldman Sachs”) and each other
    financial institution appointed as a lead arranger and/or bookrunner pursuant to the terms of the Commitment Letter (collectively,
    the “Term Loan B Lead Arrangers”).
	 	 	 
	Administrative
    Agent:	 	JPMorgan Chase Bank
    will act as sole administrative agent (in such capacity, the “Term Loan B Administrative Agent”).
	 	 	 
	Transactions:	 	As
    described in Exhibit A to the Commitment Letter.
	 	 	 
	Lenders:	 	JPMorgan Chase Bank
    (or one of its affiliates), Goldman Sachs and a syndicate of financial institutions and other lenders (the “Term
    Loan B Lenders”) arranged by the Term Loan B Lead Arrangers as contemplated by the Commitment Letter.
	 	 	 
	Type and Amount of Facility:	 	A senior secured term
    loan B facility (the “Term Loan B Facility”) in an aggregate amount of up to $1,375.0 million.
	 	 	 
	Purpose:	 	The proceeds of the
    loans under the Term Loan B Facility will be used to finance in part the Acquisition, the Debt Repayment and the Transaction
    Costs.
	 	 	 
	Availability:	 	The
    full amount of the Term Loan B Facility must be drawn in a single drawing on the Closing Date concurrently with the consummation
    of the Acquisition. Amounts repaid or prepaid under the Term Loan B Facility may not be reborrowed.
	 	 	 
	Ranking:	 	The
    Term Loan B Facility will rank pari passu with the Existing Credit Facilities or the Backstop Facilities, as
    applicable, and other senior secured indebtedness of the Borrower.
	 	 	 
	Guarantees:	 	Substantially the same
    as and limited to those set forth in the Existing Credit Facilities. The Target and each of its subsidiaries that would be
    required to guarantee the Term Loan B Facility will, subject to the

    	D-1

    	

    

	 	 	“Guarantee
    and Collateral Provisions” as set forth in the immediately succeeding paragraph, be required to become guarantors. The
    Borrower and the guarantors are collectively referred to as the “Loan Parties.”
	 	 	 
	Guarantee
    and Collateral Provisions:	 	Subject to the Term
    Loan B Documentation Principles and the Limited Conditionality Provisions, the Borrower’s obligations shall be secured
    by a perfected first priority security interest in all of the Borrower’s and Target’s tangible and intangible
    assets, subject to limitations and exclusions which shall be substantially the same as those set forth in the Existing Credit
    Facilities.
	 	 	 
	Maturity:	 	Loans under the Term
    Loan B Facility will mature seven years after the Closing Date, and will be subject to amortization at the rate of 1.00% per
    annum with a bullet payment at the final  maturity thereof.
	 	 	 
	Interest
    Rate:	 	The Borrower may elect that the
        Term Loan B loans bear interest at a rate per annum equal to (a) the Base Rate plus 175.0 basis points or (b) the Adjusted
        LIBO Rate plus 275.0 basis points.

         

        As used herein:

         

        “Base Rate”
        shall have the meaning given to “ABR” in the Existing Credit Agreement.

         

        “Adjusted LIBO Rate”
        shall have the meaning given to “Eurodollar Rate” in the Existing Credit Agreement.

         

        In no event shall the Adjusted
        LIBO Rate be less than zero or the Base Rate be less than the one-month Adjusted LIBO Rate plus 1.00% per annum.

         

        The Borrower may select, in respect
        of Eurodollar loans, Interest Periods of one week or one, two, three or six months or such shorter or longer period as
        may be consented to by each Term Loan B Lender.

         

        Interest will be payable in arrears
        (a) with respect to each Base Rate Loan, on the first business day of each calendar quarter during the term of such Base
        Rate Loan and (b) with respect to each Eurodollar Loan, on the last day of the applicable interest period relating thereto;
        provided that in the event that the interest period for a Eurodollar Loan shall be for a period in excess of three
        months, then interest shall also be payable on each three month anniversary of the commencement of such interest period.

    	D-2

    	

    

	Original
    Issue Discount:	 	0.50%
    
	 	 	 
	Default
    Rate:	 	Subject
    to the Term Loan B Documentation Principles, substantially the same as and limited to those set forth in the Existing Credit
    Facilities.
	 	 	 
	Mandatory
    Prepayment:	 	Subject to the Term
        Loan B Documentation Principles, substantially the same as those set forth in the Existing Credit Facilities and including
        mandatory prepayments for the following:

         

        (a) 100%
        of the net cash proceeds received by the Borrower or any of its restricted subsidiaries from any Asset Sale or Recovery
        Event consummated after the Closing Date, subject to reinvestment rights and other limitations, provided that such
        mandatory prepayments shall be shared on a pro rata basis with the equivalent mandatory prepayment requirements under
        the TLB Backstop Facility (whether or not documented as a Combined Term Facility (as defined in Exhibit C)).

         

        (b) 100%
        of the net cash proceeds received by the Borrower from any debt issuance (other than Permitted Debt or the Transactions
        described in Exhibit A) after the Closing Date; provided that (i) until the first anniversary of the Closing
        Date no such mandatory prepayments shall be required under this clause (b) with respect to the incurrence of unsecured
        debt until such amounts are applied in satisfaction of the equivalent mandatory prepayment or commitment reduction requirements
        under the HY Bridge Facility (or the HY Bridge Facility is no longer outstanding), (ii) if the HY Bridge Facility is no
        longer outstanding or the equivalent mandatory prepayment or commitment reduction requirements with respect thereto have
        already been satisfied but the 364-day Bridge Facility is outstanding, the Borrower may, in its discretion, apply such
        proceeds in satisfaction of any equivalent mandatory prepayment or commitment reduction requirements under the 364-day
        Bridge Facility or to the Term Loan B Facility pursuant this clause (b) (or any combination of the foregoing) and (iii)
        if such proceeds are applied to the Term Loan B Facility pursuant to this clause (b), such mandatory prepayments shall
        be shared on a pro rata basis with the equivalent mandatory prepayment requirements under the TLB Backstop Facility (whether
        or not documented as a Combined Term Facility).

         

        (c)
        50% of Excess Cash Flow, subject to (i) reduction to 25%

    	D-3

    	

    

	 	 	upon
        the Consolidated Secured Leverage Ratio being equal to or less than 3.00x and (ii) elimination upon the Consolidated Secured
        Leverage Ratio being equal to 2.50x, payable within 10 business days after delivery of the annual audited financial statements
        (starting with the fiscal year ending December 31, 2018); provided that the amount of the prepayment otherwise
        required from Excess Cash Flow shall be reduced on a dollar for dollar basis by (x) the amount of voluntary prepayments
        of any long-term indebtedness, including the aggregate amount of any prepayment of the 364-day Bridge Facility and any
        permanent reductions of the Senior Secured Facility commitments during such fiscal year and, at the option of the Borrower,
        after year end and prior to the time such Excess Cash Flow Payment is due, (y) internally generated cash (to be defined
        to exclude the proceeds of financings other than revolver draws) used or contractually committed to be used within a time
        limit to be agreed for capital expenditures, Permitted Acquisitions and other investments, and certain restricted payments,
        in each case, during such fiscal year and, at the option of the Borrower, after year end and prior to the time such Excess
        Cash Flow Payment is due and (z) solely to the extent such Excess Cash Flow is attributable to foreign subsidiaries, amounts
        that may not be repatriated and applied to prepayments without material adverse tax consequences for the Borrower; provided that such mandatory prepayments shall be shared on a pro rata basis with the equivalent mandatory prepayment requirements
        under the TLB Backstop Facility (whether or not documented as a Combined Term Facility).

         

        Any mandatory prepayments
        required under this paragraph will be applied as directed by the Borrower.

	 	 	 
	Optional
    Prepayment and Call Protection:	 	Subject to the Term
        Loan B Documentation Principles, substantially the same as and limited to those set forth in the Existing Credit Facilities;
        provided that any voluntary prepayments of Term Loan B loans made in the first six months following the Closing
        Date in the event of a Repricing Transaction will be subject to a 1.00% prepayment premium.

         

        “Repricing
        Transaction” means, in connection with a transaction the primary purpose of which is to prepay, refinance, substitute
        or replace the Term Loan B Facility or to amend the Term Loan B Facility to reduce the Yield (as defined in Exhibit C),
        (a) the

    	D-4

    	

    

	 	 	prepayment,
    refinancing, substitution or replacement of all or a portion of the Term Loan B Facility with the incurrence of any long-term
    debt financing by the Borrower or any restricted subsidiaries having a Yield at the time of incurrence thereof that is less
    than the Yield of such Term Loan B loans at the time of such incurrence or (b) any amendment to the credit agreement that,
    directly or indirectly, reduces the Yield of the Term Loan B loans. No “Repricing Transaction” shall be deemed
    to occur in connection with any change of control, initial public offering or transformative investment or acquisition (each
    such term to be defined in a manner to be mutually agreed).
	 	 	 
	Documentation:	 	The
    definitive documentation for the Term Loan B Facility (the “Term Loan B Documentation”) will be drafted
    by counsel to Borrower, negotiated in good faith by Borrower and the Commitment Parties and will be based on the Existing
    Credit Agreement (and may be incurred as an incremental term loan under the Existing Credit Agreement), as in effect on the
    date of the Commitment Letter but after giving effect to the Specified Amendments, and solely with such other modifications
    thereto as are required to reflect (a) the terms and conditions set forth in this Exhibit D, (b) scheduled exceptions
    to the representations and warranties to be subject to the reasonable approval of the Term Loan B Lead Arrangers, except with
    respect to any exceptions scheduled to the Existing Credit Facilities or otherwise previously disclosed to the Commitment
    Parties) and (c) modifications to the Existing Credit Facilities to account for changes in law or accounting standards or
    to cure mistakes or defects (it being understood that if a modification of any provision in the definitive documentation is
    proposed pursuant to this clause (c), but the Borrower and the Term Loan B Lead Arrangers fail to mutually agree on any modification
    of such provision in the requisite time period to allow effectiveness on the Closing Date, such provision shall be in the
    form of the corresponding provision of the Existing Credit Facilities). The Term Loan B Documentation shall contain only those
    conditions to borrowing, mandatory prepayments, representations and warranties, affirmative and negative covenants and events
    of default set forth in this Exhibit D, which, subject to the preceding sentence, shall be substantially consistent
    with, but no less favorable to the Borrower in any respect than, the Existing Credit Facilities. In the event that the TLB
    Backstop Facility becomes effective, the Term Loan B Facility may be documented together with the TLB Backstop Facility as
    a Combined Term Facility (as defined in Exhibit C). The principles set forth in this paragraph
    are referred to as the “Term Loan B Documentation Principles.”
	 	 	 
	Conditions
    Precedent to	 	The
    availability of the borrowing under the Term Loan B Facilities

    	D-5

    	

    

	Closing
    Date Borrowing:	 	on
    the Closing Date shall only be subject to the Limited Conditionality Provisions and the applicable conditions set forth in
    Exhibit H to the Commitment Letter.
	 	 	 
	Representations
    and Warranties:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities, it being understood that the representations and warranties made on
    the Closing Date will cover the Target and its subsidiaries (in the case of “excluded subsidiaries” of the Target,
    only to the extent such representations and warranties cover the “excluded subsidiaries” of the Borrower) and
    the Acquisition and the other Transactions.
	 	 	 
	Affirmative
    Covenants:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Negative
    Covenants:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions,
    substantially the same as and limited to those set forth in the Existing Credit Facilities.
	 	 	 
	Financial
    Covenants:	 	The
    Term Loan B Facility will not be subject to any financial covenants.
	 	 	 
	Events
    of Default:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities; provided that if documented as an incremental facility, the Term Loan
    B Facility will not have an Event of Default as a result of a breach of the financial covenant benefitting the Existing RC
    Facility lenders and the Existing TLA Facility lenders unless the lenders thereunder accelerate the maturity of the Existing
    RC Facility or Existing TLA Facility, as applicable, as a result of such breach.
	 	 	 
	Cost
    and Yield Protection:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Assignments
    and Participation:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Voting:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.

    	D-6

    	

    

	Expenses
    and Indemnification:	 	Subject
    to the Term Loan B Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Governing
    Law and Forum:	 	New
    York, including exclusive New York jurisdiction.
	 	 	 
	Counsel
    to Backstop Administrative Agent and Backstop Lead Arrangers:	 	Simpson
    Thacher & Bartlett LLP.
	 	 	 
	Counsel
    to Borrower:	 	Sullivan
    & Cromwell LLP.

    	D-7

    	

    

	CONFIDENTIAL	EXHIBIT E

 

Project Cobra

364-day Senior Unsecured Bridge Facility

Summary of Principal Terms and Conditions

 

Capitalized terms
used but not defined in this Exhibit E shall have the meanings set forth in the Commitment Letter to which this Exhibit
E is attached or the other Exhibits to the Commitment Letter.

 

	Borrower:	 	Gartner,
    Inc., a Delaware corporation (the “Borrower”).
	 	 	 
	Lead Arrangers and Bookrunner:	 	JPMorgan
    Chase Bank, N.A. (“JPMorgan Chase Bank”), Goldman Sachs Bank USA (“Goldman Sachs”) and
    each other financial institution appointed as a lead arranger and/or bookrunner pursuant to the terms of the Commitment Letter
    (collectively, the “364-day Bridge Lead Arrangers”).
	 	 	 
	Administrative Agent:	 	JPMorgan
    Chase Bank will act as sole administrative agent (in such capacity, the “364-day Bridge Administrative Agent”).
	 	 	 
	Transactions:	 	As
    described in Exhibit A to the Commitment Letter.
	 	 	 
	Lenders:	 	JPMorgan
    Chase Bank (or one of its affiliates), Goldman Sachs and a syndicate of financial institutions and other lenders (the “364-day
    Bridge Lenders”) arranged by the 364-day Bridge Lead Arrangers as contemplated by the Commitment Letter.
	 	 	 
	Type and Amount of Facility:	 	A senior
    unsecured 364-day bridge loan facility (the “364-day Bridge Facility”) under which the 364-day Bridge Lenders
    will make senior increasing rate loans (the “364-day Bridge Loans”) to the Borrower on the Closing Date
    in an aggregate principal amount of up to $300.0 million, less all reductions on or prior to the Closing Date pursuant
    to the “Mandatory Prepayment/Commitment Reductions” section below.
	 	 	 
	Purpose:	 	The
    proceeds of the 364-day Bridge Loans will be used to finance in part the Acquisition, the Debt Repayment and the Transaction
    Costs until such time that the Borrower completes a repatriation to the United States of cash held in certain foreign subsidiaries.
	 	 	 
	Availability:	 	The
    full amount of the 364-day Bridge Facility must be drawn in a single drawing on the Closing Date concurrently with the consummation
    of the Acquisition. Amounts repaid or prepaid under the 364-day Bridge Facility may not be reborrowed.

    	E-1

    	

    

	Ranking:	 	The
    364-day Bridge Loans will rank pari passu with other senior unsecured indebtedness of the Borrower.
	 	 	 
	Guarantees:	 	Substantially
    the same as and limited to those set forth in the Existing Credit Facilities. The Target and each of its material domestic
    subsidiaries that would be required to guarantee the Existing Credit Facilities will be required to become guarantors. The
    Borrower and the guarantors are collectively referred to as the “Loan Parties.”
	 	 	 
	Maturity:	 	The
    Bridge Loans will mature on the day that is 364 days after the Closing Date, and will not be subject to scheduled amortization
    prior to the final maturity thereof.
	 	 	 
	Interest Rates:	 	The Borrower may elect that the
        364-day Bridge Loans bear interest at a rate per annum equal to (a) the Base Rate plus 175.0 basis points or (b)
        the Adjusted LIBO Rate plus 275.0 basis points. Such margins will increase by (a) 25.0 basis points 180 days after
        the Closing Date and (b) an additional 25.0 basis points each 90 days thereafter.

         

        In no event shall the Adjusted
        LIBO Rate be less than zero or the Base Rate be less than the one-month Adjusted LIBO Rate plus 1.00% per annum.

         

        The Borrower may select, in respect
        of Eurodollar loans, Interest Periods of one week or one, two, three or six months or such shorter or longer period as
        may be consented to by each 364-day Bridge Lender.

         

        Interest will be payable in arrears
        (a) with respect to each Base Rate Loan, on the first business day of each calendar quarter during the term of such Base
        Rate Loan and (b) with respect to each Eurodollar Loan, on the last day of the applicable interest period relating thereto;
        provided that in the event that the interest period for a Eurodollar Loan shall be for a period in excess of three
        months, then interest shall also be payable on each three month anniversary of the commencement of such interest period.

    	E-2

    	

    

	Duration
    Fees:	 	The
    Borrower shall pay duration fees for the account of each 364-day Bridge Lender in amounts equal to the percentage, determined
    in accordance with the grid below, of the aggregate principal amount of the 364-day Bridge Loans of such 364-day Bridge Lender
    outstanding at the close of business, New York City time, on each date set forth in the grid below.
	 	 	 

	Duration
    Fees
	90
    days after the

Closing Date	180
    days after the

Closing Date	270
    days after the

Closing Date
	25
    bps	100
    bps	100
    bps

	 	 	 
	Default Rate:	 	Upon
    and during the continuance of any payment event of default or bankruptcy event of default, with respect to principal, the
    applicable interest rate plus 2.00% per annum and, with respect to any other amount, the interest rate applicable to the 364-day
    Bridge Loans that are Base Rate Loans plus 2.00% per annum.
	 	 	 
	Mandatory Prepayments/Commitment
    Reductions:	 	The Borrower shall prepay the
        364-day Bridge Loans or, prior to the funding of the 364-day Bridge Facility on the Closing Date, the commitments in respect
        of the 364-day Bridge Facility shall automatically reduce, in an aggregate amount equal to:

         

        (a)     100%
        of any net cash proceeds received by the Borrower as a distribution or dividend from any Foreign Subsidiary (as defined
        in the Existing Credit Facilities) of the Borrower (other than in the ordinary course), less the amount of taxes payable
        or reasonably estimated by the Borrower to be payable as a result of such repatriation (it being understood that this
        clause shall not apply to intercompany payments including repayment of receivables or intercompany debt); and

         

        (b)     100%
        of the net cash proceeds received by the Borrower from any Specified Debt Incurrence or Specified Equity Issuance after
        the Closing Date; provided that (i) no such mandatory prepayments shall be required under this clause (b) with
        respect to the incurrence of any Specified Debt Incurrence constituting secured debt, (ii) no such mandatory prepayments
        shall be required under this clause (b) with respect to any debt or equity until such amounts are applied in satisfaction
        of the equivalent mandatory prepayment or commitment reduction requirements under the HY Bridge Facility (or such Facility
        is no longer outstanding), (iii) if the HY Bridge Facility is no longer outstanding or the equivalent mandatory prepayment
        or commitment

    	E-3

    	

    

	 	 	reduction requirements
        with respect thereto have already been satisfied, the Borrower may, in its discretion, apply such proceeds pursuant to
        this clause (b) or any equivalent mandatory prepayment or commitment reduction requirements under the TLB Backstop Facility
        and Term Loan B Facility (or any combination of the foregoing) and (iv) no such mandatory prepayments shall be required
        under this clause (b) with respect to the proceeds from any offering of the Notes.

         

        As used herein:

         

        “Specified Debt
        Incurrence”         means any issuance or incurrence of (a) the Notes, (b) any other debt securities (including
        debt securities convertible         into equity and any equity-linked or hybrid debt-equity securities) of the Borrower or
        any of its restricted subsidiaries,         in each case, whether pursuant to a public offering or in a Rule 144A or other
        private placement, (c) indebtedness under         any loan or other credit facility (other than the 364-day Bridge Facility,
        the HY Bridge Facility, Backstop Facilities         or Term Loan B Facility) of the Borrower or any of its restricted
        subsidiaries and (d) any other indebtedness for borrowed         money of the Borrower or any of its restricted subsidiaries,
        in each case, other than (i) intercompany debt between the         Borrower and its restricted subsidiaries, (ii) for the
        avoidance of doubt, indebtedness of the Borrower and its subsidiaries         and other subsidiaries that are “excluded
        subsidiaries” under the Existing Credit Facility, including, after         the Closing Date, (iii) borrowings under the
        Existing Credit Facilities (but not any incremental commitments thereunder         effected after the date of the Commitment
        Letter), (iv) refinancings of any existing indebtedness of the Borrower, provided that such refinancing does not
        increase the aggregate outstanding amount thereof, other than by the amount of accrued         and unpaid interest on the
        indebtedness being refinanced and the amount of any costs, fees and expenses incurred in connection         therewith, (v)
        deferred purchase price obligations, (vi) ordinary course working capital facilities (other than any revolving         credit
        facilities), (vii) ordinary course capital leases, purchase money and equipment financings, (viii) any Permitted         Debt
        and (ix) any indebtedness of the Target and its subsidiaries incurred prior to the Closing Date permitted to be incurred
        and remain outstanding pursuant to the Acquisition Agreement.

         

        “Specified
        Equity Issuance” means any issuance of common equity, preferred equity or other equity securities by the Borrower,
        whether pursuant to a public offering or in a Rule 144A or other private placement, other than (a) any equity securities
        issued pursuant to employee stock plans or other employee compensation plans, (b) equity securities issued as consideration
        in the Acquisition or in any other acquisition, (c) issuances of directors’ qualifying shares and/or

    	E-4

    	

    

	 	 	other
    nominal amounts required to be held by persons (other than the Borrower or its subsidiaries under applicable law) by the Borrower
    or any of its subsidiaries or (d) issuances of Permitted Preferred Stock (as defined in the Existing Credit Facilities), in
    each case on or after the date of the Commitment Letter.
	 	 	 
	Optional Prepayment:	 	The
    364-day Bridge Loans may be prepaid at any time, in whole or in part, at par plus accrued and unpaid interest to the date
    of prepayment but without premium or penalty, subject to reimbursement of the Bridge Lenders’ breakage costs, upon not
    less than three (3) business days’ prior written notice, at the option of the Borrower.
	 	 	 
	Documentation:	 	The
    definitive documentation for the 364-day Bridge Facility (the “364-day Bridge Documentation”) will be drafted
    by counsel to Borrower, negotiated in good faith by Borrower and the Commitment Parties and will be based on the Existing
    Credit Agreement, as in effect on the date of the Commitment Letter but after giving effect to the Specified Amendments, and
    solely with such other modifications thereto as are required to reflect (a) the terms and conditions set forth in this Exhibit
    E, (b) the interim nature of the 364-day Bridge Facility and the fact that the 364-day Bridge Facility is an unsecured
    term loan facility, (c) the 364-day Bridge Administrative Agent’s customary agency and mechanical provisions, (d) scheduled
    exceptions to the representations and warranties to be subject to the reasonable approval of the 364-day Bridge Lead Arrangers,
    except with respect to any exceptions scheduled to the Existing Credit Facilities or otherwise previously disclosed to the
    Commitment Parties and (e) modifications to the Existing Credit Agreement that are mutually agreed to account for changes
    in law or accounting standards or to cure mistakes or defects (it being understood that if a modification of any provision
    in the definitive documentation is proposed pursuant to this clause (e), but the Borrower and the 364-day Bridge Lead Arrangers
    fail to mutually agree on any modification of such provision in the requisite time period to allow drawing on the Closing
    Date, such provision shall be in the form of the corresponding provision of the Existing Credit Agreement). The 364-day Bridge
    Documentation shall contain only those conditions to borrowing, mandatory prepayments, representations and warranties, affirmative,
    negative and financial covenants and events of default expressly set forth in this Exhibit E, which, subject to the
    preceding sentence, shall be substantially consistent with, but no less favorable to the Borrower in any respect than, the
    Existing Credit Agreement. The principles set forth in this paragraph are referred to
    as the “364-day Bridge Documentation Principles.”
	 	 	 
	Conditions Precedent
    to	 	The
    availability of the borrowing under the 364-day Bridge Facility on

    	E-5

    	

    

	Borrowing:	 	the
    Closing Date shall only be subject to the Limited Conditionality Provisions and the applicable conditions set forth in Exhibit
    H to the Commitment Letter.
	 	 	 
	Representations and Warranties:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement, it being understood that the representations and warranties made on the
    Closing Date will cover the Target and its subsidiaries (in the case of “excluded subsidiaries” of the Target,
    only to the extent such representations and warranties cover the “excluded subsidiaries” of the Borrower) and
    the Acquisition and the other Transactions.
	 	 	 
	Affirmative Covenants:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement (as modified by the Specified Amendment).
	 	 	 
	Negative Covenants:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement (as modified by the Specified Amendment).
	 	 	 
	Financial Covenants:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement (as modified by the Specified Amendment).
	 	 	 
	Events of Default:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement.
	 	 	 
	Cost and Yield Protection:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Agreement.
	 	 	 
	Assignments and Participation:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Voting:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Expenses and Indemnification:	 	Subject
    to the 364-day Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and

    	E-6

    	

    

	 	 	limited
    to those set forth in the Existing Credit Facilities.
	 	 	 
	Governing Law and Forum:	 	New
    York, including exclusive New York jurisdiction.
	 	 	 
	Counsel to 364-day Bridge
    Administrative Agent and 364-day Bridge Lead Arrangers:	 	Simpson Thacher & Bartlett
    LLP.
	 	 	 
	Counsel to Borrower:	 	Sullivan
    & Cromwell LLP.

    	E-7

    	

    

	CONFIDENTIAL	EXHIBIT F

 

Project Cobra

HY Bridge Facility

Summary of Principal Terms and Conditions

 

Capitalized terms used but not
defined in this Exhibit F shall have the meanings set forth in the Commitment Letter to which this Exhibit F is attached
or the other Exhibits to the Commitment Letter.

 

	Borrower:	 	Gartner, Inc., a Delaware corporation (the “Borrower”).
	 	 	 
	Lead Arrangers and Bookrunner:	 	Goldman Sachs Bank USA (“Goldman Sachs”) and JPMorgan Chase Bank, N.A. (“JPMorgan”) and each other financial institution appointed as a lead arranger and/or bookrunner pursuant to the terms of the Commitment Letter (collectively, the “HY Bridge Lead Arrangers”).
	 	 	 
	Administrative Agent:	 	Goldman Sachs will act as sole administrative agent (in such capacity, the “HY Bridge Administrative Agent” and, together with the Existing Credit Facilities Administrative Agent, the Backstop Administrative Agent, the Term Loan B Administrative Agent, the 364-day Bridge Administrative Agent, the “Administrative Agents” and each, an “Administrative Agent”).
	 	 	 
	Transactions:	 	As described in Exhibit A to the Commitment Letter.
	 	 	 
	Lenders:	 	Goldman Sachs, JPMorgan (or one of its affiliates), and a syndicate of financial institutions and other lenders (the “HY Bridge Lenders”) arranged by the HY Bridge Lead Arrangers as contemplated by the Commitment Letter.
	 	 	 
	Type and Amount of Facility:	 	A senior unsecured high yield bridge loan facility (the “HY Bridge Facility”) in an aggregate principal amount of up to $600.0 million; provided that such principal amount will be reduced by the aggregate principal amount of Notes (or other Specified Debt Incurrence or any Specified Equity Issuance) which are funded into escrow prior to the Closing Date (if any) or as otherwise agreed by the HY Bridge Lead Arrangers (it being understood that (a) the first $600.0 million of principal amount of Notes issued prior to the Closing Date shall reduce the HY Bridge Facility before reducing any other Facility and (b) any such issuance of Notes (or other Specified Debt Incurrence or any Specified Equity Issuance) prior to the Closing Date shall be issued (or deemed issued) into escrow) or that are funded on the Closing Date.
	 	 	 
	Purpose:	 	The proceeds of the loans under the HY Bridge Facility will be used to finance in part the Acquisition, the Debt Repayment and the

    	F-1

    	

    

	 	 	Transaction Costs.
	 	 	 
	Availability:	 	The full amount of the HY Bridge Facility will be made available on the Closing Date. 
	 	 	 
	Ranking:	 	The loans under the HY Bridge Facility (the “HY Bridge Loans”) will rank pari passu with other senior unsecured indebtedness of the Borrower.
	 	 	 
	Guarantees:	 	Substantially the same as and limited to those set forth in the Existing Credit Facility. The Target and each of its material domestic subsidiaries that would be required to guarantee the Existing Credit Facility will be required to become guarantors. The Borrower and the guarantors are collectively referred to as the “Loan Parties.”
	 	 	 
	Maturity/Exchange:	 	
        The HY Bridge Loans will initially mature on the first
        anniversary of the Closing Date (the “Initial HY Maturity Date”), with such maturity to be extended as provided
        below. If any of the HY Bridge Loans have not been previously repaid in full on or prior to the Initial HY Maturity Date and no
        bankruptcy (with respect to the Borrower) event of default then exists, such HY Bridge Loans shall automatically be extended to
        the eighth anniversary of the Closing Date (the “Extended Term Loans”). The Lenders in respect of such Extended
        Term Loans will have the option at any time or from time to time after the Initial HY Maturity Date to receive Exchange Notes (the
        “Exchange Notes”) in exchange for such Extended Term Loans having the terms set forth in the term sheet attached
        hereto as Exhibit G; provided that a Lender may not elect to exchange its outstanding Extended Term Loans for Exchange
        Notes unless the conditions set forth in Exhibit G under “Principal Amount” have been satisfied.

         

        The HY Bridge Loans, the Extended Term Loans and the
        Exchange Notes shall rank pari passu for all purposes.

	 	 	 
	Interest Rates:	 	Prior to the Initial HY Maturity Date, the Borrower may elect that the HY Bridge Loans bear interest at a rate per annum equal to (a) the Base Rate (as defined in Exhibit D hereto) plus 3.50% (the “Initial Margin”) or (b) the Adjusted LIBO Rate (as defined in Exhibit D hereto) plus 4.50%.  Such margins will increase by 50.0 basis points every 90 days after the Closing Date. At no time shall the interest rate in effect on the HY Bridge Loans exceed the Total Cap (as defined in the Arranger Fee Letter).
	 	 	 
	 	 	Upon the occurrence of a Demand Failure Event (as defined in the Arranger Fee Letter), the outstanding HY Bridge Loans shall

    	F-2

    	

    

	 	 	
        automatically begin to bear interest at the Total Cap.

         

        In no event shall the Adjusted LIBO Rate be less than 1.00% or the Base
        Rate be less than the one-month Adjusted LIBO Rate plus 1.00% per annum.

         

        The Borrower may select, in respect of Eurodollar loans, Interest Periods
        of one week or one, two or three months or such shorter or longer period as may be consented to by each HY Bridge Lender.

         

        Interest will be payable in arrears (a) with respect to each Base Rate
        Loan, on the first business day of each calendar quarter during the term of such Base Rate Loan and (b) with respect to each Eurodollar
        Loan, on the last day of the applicable interest period relating thereto; provided that in the event that the interest
        period for a Eurodollar Loan shall be for a period in excess of three months, then interest shall also be payable on each three
        month anniversary of the commencement of such interest period.

         

	Mandatory Prepayments:	 	
        Subject to the HY Documentation Principles, substantially
        the same as those set forth in the Existing Credit Facilities and including mandatory prepayments for the following:

	 	 	 
	 	 	 	(a)	100% of the net cash proceeds received by the Borrower from any Specified
Debt Incurrence after the Closing Date; provided that no such mandatory prepayments shall be required under this clause
(a) until the first anniversary of the Closing Date with respect to any Specified Debt Incurrence constituting secured debt; and
	 	 	 	 	 
	 	 	 	(b)	100% of the net cash proceeds received by the Borrower from any Specified Equity Issuance after the Closing Date.
	 	 	 
	Optional Prepayment:	 	The HY Bridge Loans may be prepaid at any time, in whole or in part, at par plus accrued and unpaid interest to the date of prepayment but without premium or penalty upon not less than three (3) business days’ prior written notice, at the option of the Borrower.
	 	 	 
	Documentation:	 	The definitive documentation for the HY Bridge Facility (the “HY Bridge Documentation) will be drafted by counsel to Borrower, negotiated in good faith by Borrower and the Commitment Parties and will be based on the Existing Credit Agreement, as in effect on the date of the Commitment Letter but after giving effect to the Specified Amendment and solely with such other modifications thereto as are required to reflect (a) the terms and conditions set forth in this Exhibit F, (b) the interim nature of the HY Bridge Facility and the fact

    	F-3

    	

    

	 	 	that the HY Bridge Facility is an unsecured term loan facility, (c) the HY Bridge Administrative Agent’s customary agency and mechanical provisions, (d) scheduled exceptions to the representations and warranties to be subject to the reasonable approval of the HY Bridge Lead Arrangers, except with respect to any exceptions scheduled to the Existing Credit Facilities and (e) such modifications as may be appropriate to reflect the differences between the Existing Credit Facility and a high-yield bridge.  The HY Bridge Documentation shall contain only those conditions to borrowing, mandatory prepayments, representations and warranties, affirmative and negative covenants and events of default expressly set forth in this Exhibit F, which, subject to the preceding sentence, shall be substantially consistent with those included in customary “high-yield” bridge financings of this type, including customary incurrence-based negative covenants and not including any financial maintenance covenants. The principles set forth in this paragraph are referred to as the “HY Bridge Documentation Principles.”
	 	 	 
	Conditions Precedent to Borrowing:	 	The availability of the borrowing under the HY Bridge Facility on the Closing Date shall only be subject to the Limited Conditionality Provisions and the applicable conditions set forth in Exhibit H to the Commitment Letter.
	 	 	 
	Representations and Warranties:	 	Subject to the  HY Bridge Documentation Principles and the Limited Conditionality Provisions, substantially consistent with customary “high-yield” bridge financings of this type, it being understood that the representations and warranties made on the Closing Date will cover the Target and its subsidiaries (in the case of “excluded subsidiaries” of the Target, only to the extent such representations and warranties cover the “excluded subsidiaries” of the Borrower) and the Acquisition and the other Transactions.
	 	 	 
	Covenants:	 	Subject to the HY Bridge Documentation Principles and the Limited Conditionality Provisions, the HY Bridge Facility will contain such affirmative and incurrence-based negative covenants as are usual and customary for “high-yield” bridge financings of this type, subject to (i) modifications to reflect current market conditions and other modifications to be mutually agreed and (ii) it being understood and agreed that prior to the Initial HY Maturity Date, certain covenants of the HY Bridge Loans may be more restrictive than those of the Extended Term Loans and the Exchange Notes, as reasonably agreed by the HY Bridge Lead Arrangers and the Borrower. The HY Bridge Facility will not include any financial covenants.
	 	 	 
	Events of Default:	 	Usual for facilities and transactions of this type, and others as reasonably agreed by the HY Bridge Lead Arrangers and the

    	F-4

    	

    

	 	 	Borrower. Following the Initial HY Maturity Date, the events of default relevant to the HY Bridge Loans will automatically be modified so as to be consistent with the Exchange Notes.
	 	 	 
	Cost and Yield Protection:	 	Subject to the  HY Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited to those set forth in the Existing Credit Facilities.
	 	 	 
	Assignments and Participation:	 	Subject to the  HY Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited to those set forth in the Existing Credit Facilities.
	 	 	 
	Voting:	 	Subject to the  HY Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited to those set forth in the Existing Credit Facilities.
	 	 	 
	Expenses and Indemnification:	 	Subject to the  HY Bridge Documentation Principles and the Limited Conditionality Provisions, substantially the same as and limited to those set forth in the Existing Credit Facilities.
	 	 	 
	Governing Law and Forum:	 	New York, including exclusive New York jurisdiction.
	 	 	 
	Counsel to HY Bridge Administrative Agent and HY Bridge Lead Arrangers:	 	Simpson Thacher & Bartlett LLP.
	 	 	 
	Counsel to Borrower:	 	Sullivan & Cromwell LLP.

    	F-5

    	

    

	CONFIDENTIAL	EXHIBIT G

 

Project Cobra

Exchange Notes and Extended Term Loans

Summary of Principal Terms and Conditions

 

Capitalized terms used but not
defined in this Exhibit G shall have the meanings set forth in the Commitment Letter to which this Exhibit G is attached
or the other Exhibits to the Commitment Letter.

 

	Issuer:	 	Gartner, Inc., a Delaware corporation (the “Issuer”).
	 	 	 
	Guarantors:	 	
        Same as the HY Bridge Loans.

         

        The guarantees shall rank pari passu
        with all senior unsecured indebtedness and shall rank senior to all subordinated indebtedness of such Guarantors.

	 	 	 
	Principal Amount:	 	The Exchange Notes will be available only in exchange for the Extended Term Loans on or after the Initial HY Maturity Date. The principal amount of any Exchange Note will equal 100% of the aggregate principal amount of the Extended Term Loan for which it is exchanged, and any accrued interest then not due will be carried over. In the case of the initial exchange by Lenders, the minimum amount of Extended Term Loans to be exchanged for Exchange Notes shall not be less than $100.0 million.
	 	 	 
	Maturity:	 	The Exchange Notes and Extended Term Loans will mature on the eighth anniversary of the Closing Date.
	 	 	 
	Interest Rate:	 	The Exchange Notes and Extended Term Loans will bear interest at a fixed rate equal to the Total Cap (as defined in the Arranger Fee Letter).
	 	 	 
	Equity Clawback:	 	Exchange Notes and Extended Term Loans will be subject to an equity clawback of up to 40% of the outstanding value until the third anniversary of the Closing Date.
	 	 	 
	Optional Redemption:	 	In the case of Exchange Notes held by a HY Bridge Lender or any affiliate thereof (other than bona fide investment funds and entities that manage assets on behalf of unaffiliated third parties (the “Asset Management Affiliates”) and excluding Exchange Notes acquired pursuant to bona fide open market purchases from third parties or market making activities (“Repurchased Securities”)), the Issuer may redeem such Exchange Notes in whole or in part at par plus accrued and unpaid interest at any time after the issuance thereof.

    	G-1

    	

    

	 	 	
        Exchange Notes held by any party that is not an
        HY Bridge Lender or an affiliate thereof (other than Asset Management Affiliates and other than with respect to Repurchased Securities)
        will be non-callable until the third anniversary of the Closing Date, Thereafter, each Exchange Note will be callable at par plus
        accrued interest plus a premium equal to three quarters of the coupon on such Exchange Note, which premium will decline ratably
        on each yearly anniversary of the Closing Date to zero on the date that is two years prior to the maturity of the Exchange Notes.

         

        Prior to the third anniversary of the Closing Date,
        the Issuer may redeem such Exchange Notes at a make-whole price based on U.S. Treasury notes with a maturity closest to the third
        anniversary of the Closing Date plus 50 basis points.

	 	 	 
	Mandatory Offer to Purchase:	 	
        The Issuer will be required to offer to repurchase
        the Exchange Notes and repay the Extended Term Loans upon the occurrence of a change of control (as defined in the HY Bridge Documentation
        Principles) (which offer shall be at 101% of the principal amount of such Exchange Notes or the Extended Term Loans, as applicable,
        in each case plus accrued and unpaid interest).

         

        The Issuer will also be required to offer to repurchase
        the Exchange Notes and repay the Extended Term Loans upon the sale of certain assets (which offer shall be at par plus accrued
        and unpaid interest to the repurchase date).

	 	 	 
	HY Bridge Rollover Fee:	 	If and to the extent the HY Bridge Loans are made, to the Commitment Parties, a HY Bridge Rollover Fee shall be payable in an amount equal to 1.50% of the principal amount of the HY Bridge Loans outstanding on the Initial HY Maturity Date, which shall be earned and due and payable on the Initial HY Maturity Date.
	 	 	 
	Registration Rights:	 	The Exchange Notes and Extended Term Loans shall be subject to registration rights. Holders of the Exchange Notes and Extended Term Loans will be subject to transfer restrictions under securities laws.
	 	 	 
	Covenants:	 	Subject to the HY Bridge Documentation Principles and customary for high-yield senior debt offerings, subject to modifications to reflect current market conditions and other changes to be mutually agreed.
	 	 	 
	Events of Default:	 	Subject to the HY Bridge Documentation Principles and customary for high-yield senior debt offerings, subject to modifications to reflect current market conditions and other changes to be mutually agreed.

    	G-2

    	

    

	Governing Law and Forum:	 	New York, including exclusive New York jurisdiction.
	 	 	 
	Counsel to Issuer:	 	Sullivan & Cromwell LLP.

    	G-3

    	

    

	CONFIDENTIAL	EXHIBIT H

 

Project Cobra

Conditions Precedent to Closing

 

Subject to the Limited Conditionality
Provisions and the Documentation Principles in all respects, the initial extensions of credit under the Facilities will be subject
to the satisfaction (or waiver by the Lead Arrangers) of solely the following conditions:

 

1.          The
Acquisition shall have been consummated, or substantially simultaneously with the initial
borrowing under the Facilities shall be consummated, in accordance with the Acquisition
Agreement in all material respects, and no provision of the Acquisition Agreement shall
have been waived, amended, supplemented or otherwise modified (including any consent thereunder) in a manner materially adverse
to the Lenders or the Lead Arrangers without the consent of the Lead Arrangers (such consent not to be unreasonably withheld, delayed
or conditioned); provided that (a) any increase in the purchase price shall not be deemed to be materially adverse to the
Lenders or the Lead Arrangers if it is paid for solely by an increase in the equity component of the purchase price, (b) any decrease
in the purchase price in an amount up to 10% of the aggregate purchase price shall be deemed not materially adverse to the Lenders
or the Lead Arrangers (it being understood that a change after the date hereof in the market value of the equity or stock component
of the consideration to be provided by the Borrower under the Acquisition Agreement shall not be deemed a decrease in the purchase
price thereunder), provided that such decrease in the purchase price is allocated to reduce, on a dollar-for-dollar basis,
the amount of the 364-day Bridge Facility and (c) any amendment to the definition of “Company Material Adverse Effect”
set forth in the Acquisition Agreement shall be deemed to be materially adverse to the Lenders
and the Lead Arrangers.

 

2.          The
Debt Repayment shall have been consummated, or substantially simultaneously with the initial
borrowing under the Facilities shall be consummated.

 

3.          All
fees of the Commitment Parties and the Administrative Agents payable on or prior to the Closing Date pursuant to the Fee Letters,
all fees owed to the Lenders pursuant to the Fee Letters and all expenses of the Commitment Parties required to be paid or reimbursed
on the Closing Date pursuant to the Commitment Letter (to the extent, in the case of such expenses, invoiced at least three business
days prior to the Closing Date, except as otherwise agreed by the Borrower) shall have been paid, in each case, at the Borrower’s
option, from the proceeds of the initial funding under the relevant Facility.

 

4.          The
Lead Arrangers shall have received (a) audited consolidated financial statements of the Target and its subsidiaries for the
three most recent fiscal years ended at least 60 days before the Closing Date, provided that the Lead Arrangers acknowledge
that they have received the audited consolidated financial statements for the fiscal years ended December 31, 2013, 2014 and 2015,
and (b) unaudited consolidated financial statements of the Target and its subsidiaries for each fiscal quarter (other than the
fourth fiscal quarter) ended after the date of the most recent balance sheet delivered pursuant to clause (a) above and at least
45 days before the Closing Date (and, in the case of each of clauses (a) and (b), such financial statements shall be prepared in
conformity with U.S. GAAP); provided that such financial statements specified in

    	H-1

    	

    

clause (b) shall be subject to
year-end adjustments and absence of footnotes and provided further that the Lead Arrangers acknowledge that the financial statements
delivered and prepared by the Target with respect to the fiscal quarters ended March 31, 2016, June 30, 2016 and September 30,
2016 have been received.

 

5.          The
Lead Arrangers shall have received (a) audited consolidated financial statements for the Borrower and its subsidiaries for
the three most recent fiscal years ended at least 60 days before the Closing Date, provided that the Lead Arrangers acknowledge
that they have received the audited consolidated financial statements for the fiscal years ended December 31, 2013, 2014 and 2015,
and (b) unaudited consolidated financial statements for the Borrower and its subsidiaries for each fiscal quarter (other than the
fourth fiscal quarter) ended after the date of the most recent balance sheet delivered pursuant to clause (a) above and at least
45 days before the Closing Date (and, in the case of each of clauses (a) and (b), such financial statements shall be prepared in
conformity with U.S. GAAP); provided that such financial statements specified in clause (b) shall be subject to year-end
adjustments and absence of footnotes and provided further that the Lead Arrangers acknowledge that the financial statements delivered
and prepared by you with respect to the fiscal quarters ended March 31, 2016, June 30, 2016 and September 30, 2016 have been received.

 

6.          An
unaudited pro forma consolidated balance sheet as of the end of the most recent fiscal quarter provided pursuant to clause (a)
or (b) of paragraph 4 above and pro forma consolidated income statements of the Borrower and its subsidiaries (after giving effect
to the Transactions) for each of (i) the most recent fiscal year for which audited consolidated financial statements are provided
pursuant to clause (a) above and (ii) the interim period, if any, since the date of such audited financial statements through the
most recent quarterly unaudited consolidated financial statements provided pursuant to clause (b) above and the corresponding interim
period of the precedent fiscal year (if any), in each case, presented in all material respects in accordance with Article 11 of
Regulation S-X.

 

7.          Except
as set forth in the Filed Company SEC Documents (as defined in the Acquisition Agreement as in effect on the date of the Commitment
Letter) (excluding any disclosures in the Filed Company SEC Documents in any risk factors section, in any section related to forward-looking
statements and other disclosures that are predictive or forward-looking in nature) or in the Company Disclosure Letter (as defined
in the Acquisition Agreement as in effect on the date of the Commitment Letter), from January 1, 2016 to the date of the Acquisition
Agreement, there has not occurred any fact, circumstance, effect, change, event or development that, individually or in the aggregate,
has had or would reasonably be expected to have a Company Material Adverse Effect (as defined in the Acquisition Agreement as in
effect on the date of the Commitment Letter). Since the date of the Acquisition Agreement, there shall not have occurred and be
continuing a Company Material Adverse Effect, as defined in the Acquisition Agreement (as in effect on the date of the Commitment
Letter). The interpretation of the definition of Company Material Adverse Effect and the determination of whether or not a Company
Material Adverse Effect has occurred shall be construed in accordance with the laws of the State of Delaware applicable to contracts
executed in and to be performed entirely within said state, regardless of the laws that might otherwise govern under any applicable
contract of laws principles.

    	H-2

    	

    

8.          The
Specified Representations shall be true and correct in all material respects (except for representations and warranties that are
already qualified by materiality, which representations and warranties shall be true and correct after giving effect to such materiality
qualifier).

 

9.          The
Acquisition Agreement Representations shall be true and correct in all material respects to the extent required under the Limited
Conditionality Provisions.

 

10.        The
364-day Bridge Documentation, in the case of the 364-day Bridge Facility, the Backstop Documentation, in the case of the Backstop
Facilities, the Term Loan B Documentation, in the case of the Term Loan B Facility, and the HY Bridge Documentation, in the case
of the HY Bridge Facility, shall have been executed and delivered by the Loan Parties. Subject to the Limited Conditionality Provisions,
the guarantees and the security documents required to satisfy the requirements described under the “Guarantees” and,
in respect of the Facilities, “Security” headings set forth in the applicable Term Sheet shall have been executed and
delivered by the Loan Parties.

 

11.        Subject
to the Limited Conditionality Provisions, the Lead Arrangers shall have received the following (the “Closing Deliverables”):
(a) customary legal opinions, (b) customary evidence of authority, (c) customary closing officer’s certificates (including
a certification of the aggregate amount of the reductions in the commitments in respect of the 364-day Bridge Facility occurring
pursuant to the “Mandatory Prepayments/Commitment Reductions” section in Exhibit E to the Commitment Letter,
together with a reasonably detailed calculation thereof), (d) good standing certificates (to the extent applicable) in the respective
jurisdictions of organization of the Loan Parties, (e) a solvency certificate substantially in the form set forth in Exhibit
I and (f) a customary borrowing notice.

 

12.        To
the extent requested at least 10 business days prior to the Closing Date, the Lenders shall have received all documentation and
other information required by bank regulatory authorities under applicable “know-your-customer” and anti-money laundering
rules and regulations, including the U.S.A. Patriot Act, at least three business days prior to the Closing Date.

 

13.        (a)
The Borrower shall have engaged one or more Investment Banks (as defined in the Arranger Fee Letter) and shall have provided the
Investment Banks with a preliminary offering memorandum relating to offering of the Notes by the Borrower in a form customary for
offerings of high yield debt securities under Rule 144A (other than a “description of notes” (provided that the Borrower
shall have used good faith efforts to finalize the “description of notes”)) and including all information as would
be customary in a preliminary offering memorandum for an offering of high-yield debt securities under Rule 144A, including discussion
of the Borrower and the Target, financial statements, pro forma financial statements and such other data that would enable the
Investment Banks to obtain customary comfort letters (including customary negative assurance comfort) from the Borrower’s
and the Target Business’s independent public accountants (which, for the avoidance of doubt, shall not include financial
statements required by Rule 3-10 or Rule 3-16 of Regulation S-X, information regarding executive compensation (including under
Rule 402(b) of Regulation S-K) or other information customarily excluded from a Rule 144A offering memorandum) and (b) the

    	H-3

    	

    

Investment Banks shall have been
afforded a period of at least 15 consecutive business days commencing upon the date of the delivery of the offering memorandum
described in clause (a) above to seek to offer and sell or privately place the Notes (it being understood that (i) at all times
during the Marketing Period the financial information in the preliminary offering memorandum shall be in compliance in all material
respects with all requirements of Regulation S-K and Regulation S-X as they would be applied to the offering memorandum as if it
were a prospectus under the Securities Act of 1933, as amended, and (ii) none of the information (other than the financial information)
included in the offering memorandum shall at any time during the Marketing Period contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements contained therein not misleading in light of the circumstances
under which such statements are made) (the “Notes Marketing Period”); provided that (a) such 15 consecutive
business day period shall exclude January 16, 2017, February 20, 2017, April 14, 2017, May 29, 2017 and July 4, 2017 and (b) if
the Borrower in good faith reasonably believes that it has delivered the preliminary offering memoranda required by this paragraph
13, it may deliver to the Investment Banks written notice to that effect (stating when it believes it completed the applicable
delivery), in which case such preliminary offering memoranda shall be deemed to have been delivered on the date of the applicable
notice unless the Borrower receives written objection from the Investment Banks within five business days after the date such notice
is received. If the Borrower receives such written objection and the Borrower in good faith reasonably believes that it has remedied
any deficiencies in the preliminary offering memorandum set out in such objection, it may deliver to the Investment Banks written
notice to that effect (stating when it believes it completed the applicable subsequent delivery), in which case such preliminary
offering memorandum shall be deemed to have been delivered on the date of such subsequent notice, unless the Investment Banks deliver
a subsequent written objection within five business days after the date such subsequent notice is received.

    	H-4

    	

    

	CONFIDENTIAL	EXHIBIT I

Project Cobra

Solvency Certificate

 

Pursuant to Section [·]
of the Credit Agreement, dated [·], 2017, among Gartner, Inc. (the “Borrower”),
the Lenders from time to time party thereto and [·], as administrative agent, the
undersigned hereby certifies, solely in such undersigned’s capacity as [Chief Financial Officer] of the Borrower, and not
individually, as follows:

 

As of the date hereof, after giving effect
to the consummation of the Transactions (as defined in the Credit Agreement), and after giving effect to the application of the
proceeds of such indebtedness under such Transactions:

 

		(a)	The amount of the fair saleable value of the assets of the Borrower and its Restricted Subsidiaries
on a consolidated basis exceeds:

 

		(i)	the value of all liabilities of the Borrower and its Restricted Subsidiaries (on a consolidated
basis), including contingent and other liabilities, as generally determined in accordance with applicable United States federal
laws governing determinations of the insolvency of debtors; and

 

		(ii)	the amount that will be required to pay the probable liabilities of the Borrower and its Restricted
Subsidiaries on its existing debts (including contingent liabilities) as such debts become absolute and matured;

 

		(b)	The Borrower and its Restricted Subsidiaries (on a consolidated basis) do not have an unreasonably
small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged; and

 

		(c)	The Borrower and its Restricted Subsidiaries (on a consolidated basis) will be able to pay its
liabilities, including contingent and other liabilities, as they mature.

 

For purposes of this Certificate,
each of the phrases “not have an unreasonably small amount of capital for the operation of the businesses in which they are
engaged or proposed to be engaged” and “able to pay their liabilities, including contingent and other liabilities,
as they mature” means that the Borrower and its Restricted Subsidiaries will be able to generate enough cash from operations,
asset dispositions or refinancing, or a combination thereof, to meet its obligations as they become due. Capitalized terms used
but not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.

 

The undersigned is familiar
with the business and financial position of the Borrower and its Restricted Subsidiaries. In reaching the conclusions set forth
in this Certificate, the undersigned has made such other investigations and inquiries as the undersigned has deemed appropriate,
having taken into account the nature of the particular business anticipated to be conducted by the Borrower and its Restricted
Subsidiaries after consummation of the Transactions.

    	I-1EX-10.1

 Exhibit 10.1 

SEPARATION AND RELEASE AGREEMENT 

This Separation and Release Agreement (this “Agreement”) is made by and between James D. Surek (the
“Employee”) and Entellus Medical, Inc. (the “Company”) (each a “Party” and together the “Parties”). 

RECITALS 
 WHEREAS,
the Employee is employed by the Company as its Vice President, Sales; and 
 WHEREAS, the Parties wish to conclude their employment
relationship in an honorable, dignified, and orderly manner pursuant to the negotiated terms more fully described below. 
 AGREEMENT

 NOW, THEREFORE, IN CONSIDERATION OF THE MUTUAL PROMISES CONTAINED IN THIS AGREEMENT, THE PARTIES HEREBY AGREE AS FOLLOWS:

 1.     Definitions. All words used in this Agreement are intended to have their plain meanings. The following
terms have the following meanings: 
  

	 	a)	“Affiliate” means as to any entity, any Person that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, the first entity.

  

	 	b)	“Claims” means any and all actual, suspected or potential claims, controversies, causes of action, cross-claims, counterclaims, demands, debts or liabilities of any nature whatsoever in law and
in equity, whether known, suspected or unknown, arising or accruing through the date the waiver and release provisions in this Agreement become effective, that the Employee has or may have against any of the Released Parties, seeking any form of
relief or damages, reinstatement, back pay, front pay, attorney’s fees, specific performance, injunctive relief, other equitable relief, costs, disbursements or interest arising out of or connected to the Employee’s employment with,
relationship with, or termination of employment from the Company, including without limitation, those claims arising pursuant to or under: 

  

	 	i.	Any local, state or federal statute, ordinance, rule or regulation, including without limitation, Title VII of the Civil Rights Act of 1964 (“Title VII”), the Americans with Disabilities Act
(“ADA”), the Genetic Information Nondiscrimination Act of 2008 (“GINA”), the Civil Rights Act of 1866 (42 U.S.C. § 1981), the Family Medical Leave Act (“FMLA”), the Employee Retirement Income
Security Act (“ERISA”), the Equal Pay Act (“EPA”), the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Minnesota Human Rights Act (“MHRA”), other
non-interference or non-retaliation statutes and any other federal, state, or local statute, law, rule, regulation, ordinance or order; 

	 	ii.	The Age Discrimination in Employment Act (“ADEA”) and the Older Workers Benefit Protection Act (“OWBPA”); 

 

	 	iii.	State or federal common law for any intentional or negligent act, or any act for which any Released Party might be strictly or vicariously liable; and 

 

	 	iv.	Any employment agreement or severance, separation, retention, exit incentive, employment termination, or similar plan, policy, program or practice with the Company. 

The term “Claims” does not include any claims which cannot be waived or released under applicable law including,
without limitation, claims for: (a) unemployment insurance benefits; (b) workers’ compensation benefits to the extent that such benefits are awarded by a state agency or agreed upon consistent with applicable state law;
(c) vested benefits under an employee welfare, retirement, stock option, restricted stock, restricted stock unit or stock appreciation rights plan or award agreement; (d) benefits and rights under the Consolidated Omnibus Reconciliation
Act of 1985, as amended (“COBRA”); (e) the right to enforce the terms of this Agreement; (f) defense, indemnification or contribution as provided in that certain Indemnification Agreement dated January 23, 2015
between the Parties (the “Indemnification Agreement”); (g) the enforcement of rights as a shareholder of the Company; and (h) events occurring after the date the Employee delivers a signed copy of this Agreement to the
Company. 
  

	 	c)	“Company Documents and Data” includes without limitation correspondence, emails, text messages, reports, manuals, records, spreadsheets, blueprints, plans, writings, notes, graphs, charts, sound
recordings, visual images, and other documents or materials related to the Company’s business that the Employee has obtained, generated or received while working for the Company, including all electronically stored images and other information
and data, copies, samples, computer data, disks or records of such material. 

  

	 	d)	“Person” means any individual, corporation, partnership, group, association or other person, as such term is used in Section 13(d) or Section 14(d) of the Securities Exchange Act of
1934, other than the Company, any Affiliate or any benefit plans sponsored by the Company or an Affiliate. 

  

	 	e)	“Released Parties” means the Company and its Affiliates, predecessors, successors, assigns, benefit plans, benefit plan fiduciaries and administrators, insurers, shareholders, officers,
directors, agents, employees, attorneys and anyone else who acted on the Company’s behalf, past and present, whether in their individual or official capacities. 

 

	 	f)	“Severance Benefits” means the severance benefits and payments provided in Section 5 of this Agreement. 

2.     Resignation. The Employee hereby resigns as an officer and employee of the Company effective January 5,
2017 (the “Separation Date”).  

  
 2 

 3.     Termination of Officer and Board Status. Effective January 5,
2017, the Employee hereby resigns from any and all officer, director and other positions with the Company and with any of the Company’s Affiliates. 

4.     Accrued Obligations. The Company will pay the Employee (a) all unpaid salary for the Employee’s
service up to and through the end of business on the Separation Date; (b) business expenses incurred by the Employee through the Separation Date pursuant to the Company’s expense reimbursement policies and procedures; and (c) the
Employee’s accrued and unused paid time off (120 hours) as of the Separation Date in the amount of Sixteen Thousand Seven Hundred Thirty-One Dollars ($16,731). These payments will be made on the next regular payroll distribution date or as soon
as reasonably practicable, but no later than seventy-four (74) days following the Separation Date. 
 5.     Severance
Benefits. After the Employee delivers this signed Agreement to the Company, the applicable revocation periods provided in Section 9 of this Agreement have expired, and provided the Employee does not exercise the Employee’s rights
to revoke any part of the Release of Claims as described in Section 9 of this Agreement and complies with the terms of this Agreement, the Company will provide the Employee with the following Severance Benefits: 

 

	 	a)	Severance Pay: The Company will pay the Employee severance pay equal to six (6) months of the Employee’s current base salary in the total gross amount of One Hundred Forty-Five Thousand Dollars
($145,000) (“Severance Pay”). 

  

	 	b)	 Health Insurance Benefits. If the Employee timely elects continued coverage under the Company’s group
medical plan or group dental plan pursuant to COBRA, in accordance with ordinary plan practices, for the months of February 2017 through July 2017 (the “Continuation Period”), the Company will reimburse the Employee in an amount
equal to the difference between the amount the Employee pays for such COBRA continuation coverage each month and the amount paid by a full-time active Company employee each month for the same level of coverage elected by the Employee. If the level
of the Employee’s coverage changes during the Continuation Period, as, for example, from single to family coverage or to no coverage, the amount which the Company will pay will be determined as if the new coverage level had been the level of
coverage in effect immediately prior to the Separation Date. Notwithstanding anything to the contrary contained herein, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of
continuation coverage to be, exempt from the application of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise
unable to continue to cover the Employee under its group health plans (including without limitation, Section 2716 of the Public Health Service Act), then, in either case, the Company will in its sole discretion decide to either
(A) thereafter pay to the Employee an amount equal to each remaining Company subsidy as currently taxable compensation in substantially equal monthly installments over the continuation coverage period (or the remaining portion thereof) or
(B) provide comparable medical benefits pursuant to an alternative arrangement. Any such reimbursement or payment will be made on or before the tenth (10th) day of the calendar month
following the calendar month in 

  
 3 

	 	
which any continuation coverage payment was incurred. In addition, the Company will pay to the Employee during the Continuation Period an amount equal to any Company contribution that the Company
would have made on behalf of the Employee to a health savings account (or other arrangement), had the Employee been employed by the Company and based on the Employee’s level of coverage in effect at the time of such contribution (i.e., single
or family coverage), payable in the calendar year following the calendar year for which the contribution was made. 

  

	 	c)	2016 Bonus. The Company will pay the Employee his bonus for 2016 in the amount as calculated under the bonus plan and at such times as paid to other Company employees that are participants in such bonus plan.

  

	 	d)	Extension of Post-Termination Exercise Period of Vested Stock Options. The Company and the Employee will amend the Employee’s non-qualified options to purchase Company common stock which are vested as of the
Separation Date and described on Exhibit A to this Agreement (the “Vested Options”) to extend the post-termination exercise period for such options from three months to six months (until July 5, 2017), but in no event
later than the expiration date of such options. 

  

	 	e)	Timing of Payments; Code Section 409A. Due to the six-month suspension requirement under Code Section 409A for specified key employees of publicly-held companies, the severance payments referenced in
subsection a) of this Section 5 and the health savings account replacement payments will be paid to the Employee on the first payroll date that falls on or after July 5, 2017. In the case of taxable COBRA reimbursement payments, all such
reimbursement payments will be made on or before the tenth (10th) day of the calendar month following the calendar month in which a continuation coverage payment was incurred. The COBRA
reimbursement benefits provided under this Section 5 are intended to be exempt from the requirements of Code Section 409A by reason of the separation pay plan exception under Treasury Regulation Section 1.409A-1(b)(9), and this
Section 5 will be construed and administered to give effect to such intention. 

  

	 	f)	Severance Benefits Conditioned Upon Delivery of and Compliance with this Agreement. The Company will provide these Severance Benefits only if the Employee delivers this signed Agreement to the Company, c/o Brent
A. Moen, Entellus Medical, Inc., 3600 Holly Lane North, Suite 40, Plymouth, MN 55447, no later than twenty-one (21) days after the Employee’s Separation Date and after the applicable revocation periods referenced in Section 9 of this
Agreement have expired and complies with the terms of this Agreement. 

  

	 	h)	Forfeiture of Severance Benefits Upon Revocation of Release. The Employee will forfeit his right to receive these Severance Benefits if the Employee exercises the Employee’s right to revoke any part of the
general waiver and release of Claims as provided in Section 9 of this Agreement. 

 6.     General Waiver
and Release of Claims. In exchange for the Severance Benefits and the other payments, benefits and undertakings of the Company as stated in this Agreement, the Employee knowingly and willingly waives, releases, relinquishes, concedes and
forever 

  
 4 

 
discharges all Released Parties from any and all Claims and all rights to any legal or equitable relief under any such Claims. In exchange for the Employee’s agreement to waive, release and
discharge these Claims, the Employee is receiving the Severance Benefits, which the Employee agrees constitute full and fair compensation for this waiver and release of Claims. The Released Parties do not owe the Employee anything in addition to
what the Employee is entitled to receive under this Agreement. 
 7.     Knowing Waiver and Release of Claims. The
general waiver and release of Claims provided in Section 6 of this Agreement is subject to applicable statutes including without limitation the ADEA, OWBPA, Title VII and 42 U.S.C. § 1981. The ADEA, OWBPA, Title VII and Section 1981
provide that a covered individual cannot waive a right or claim under those statutes, as amended, unless the waiver is knowing and voluntary. The Employee is advised to consult with an attorney prior to signing this Agreement and the Employee
acknowledges that the Employee has been so advised. Nothing in this Agreement interferes with the Employee’s right to challenge the knowing and voluntary nature of the Employee’s waiver and release of any ADEA Claims or the Company’s
compliance with the waiver requirements of the ADEA or the OWBPA in a court of competent jurisdiction. 
 8.     Time to
Consider. The Employee has up to twenty-one (21) days from the date the Employee receives this Agreement to sign this Agreement and return it to the Company. The Employee acknowledges that the Company has advised the Employee to use
this time to consult with an attorney about the effect of the waiver and release of Claims. If the Employee signs this Agreement before the end of the 21-day period, it is the Employee’s personal, voluntary decision to do so. Any changes made
to this Agreement before it is signed do not restart the running of this consideration period. 
 9.     Revocation
Rights. The Employee has the right to revoke the Employee’s waiver and release of the Employee’s ADEA claims by written notice of such to the Company within seven (7) calendar days following the Employee’s signing of this
Agreement. This Agreement will not become effective or enforceable as to those ADEA claims until that seven (7)-day period has expired. The Employee has the right to revoke (rescind) the Employee’s waiver and release of the Employee’s MHRA
claims by written notice of such to the Company within fifteen (15) calendar days following the Employee’s signing of this Agreement. This Agreement will not become effective or enforceable as to those MHRA claims until that fifteen
(15)-day period has expired. 
 A notice of revocation must be in writing, must state whether the revocation is applicable to the Employee’s ADEA
claims, MHRA claims or both, and must be either hand-delivered to the Company or, if sent by mail, postmarked within the appropriate revocation period, sent by certified mail, return receipt requested, and addressed to: 

  
 5 

 Brent A. Moen, Chief Financial Officer 

Entellus Medical, Inc. 

3600 Holly Lane North, Suite 40 

Plymouth, MN 55447 
 The Employee
does not have the right to revoke the waiver and release of Claims as to any other Claims. 
 The Employee understands that the Employee’s receipt of
the Severance Benefits is contingent upon the Employee’s agreement to be bound by all terms of this Agreement. Accordingly, if the Employee revokes the waiver and release of either the Employee’s ADEA claims or MHRA claims, or both,
the Employee is not entitled to the Severance Benefits. Instead, the Employee will be paid consideration of $1.00 for his release of the remaining Claims. 

10.   Employee Representations and Warranties; Limitations on Release and Additional Recovery.  

 

	 	a)	The Employee represents and warrants that the Employee is aware of no facts, evidence, allegations, claims, liabilities, or demands relating to alleged or potential violations of law that may give rise to a claim or
liability on the part of any Released Party under the Securities Exchange Act of 1934, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any other federal, state, local or international law, statute or
regulation providing for protection and/or recovery to whistleblowers. 

  

	 	b)	Nothing in this Agreement, however, should be construed as interfering with the Employee’s right or ability to file a charge, report, claim or complaint with, or to otherwise participate in any manner in an
investigation or proceeding before, any civil rights or fair employment practices regulatory or law enforcement agency or entity including, without limitation, the Equal Employment Opportunity Commission (“EEOC”), National Labor
Relations Board (“NLRB”), Occupational Safety and Health Administration (“OSHA”), Securities and Exchange Commission (“SEC”), Internal Revenue Service (“IRS”), Department of Labor
(“DOL”), Department of Justice (“DOJ”), any agency Inspector General or any other federal, state or local governmental branch, unit, agency or commission (each a “Government Agency”) against any
Released Party. The Employee further understands that this Agreement does not limit the Employee’s ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any
Government Agency, including the Employee providing such Government Agency with documents or other information, without notice to the Company. 

  

	 	c)	Notwithstanding the above, the Employee understands and agrees that the Employee waives his right to recover individual relief for the Employee in any such administrative or legal action, whether such action is brought
by a Government Agency, the Employee or any other party, unless and to the extent that such waiver is contrary to law (as is the case where an informant is entitled to an award for providing original and useful information leading to a
successful enforcement action by a Government Agency). 

  
 6 

	 	d)	Notwithstanding any other provisions in this Agreement or in any trade secret or confidential information agreement between the Employee and the Company including, without limitation, that certain Confidentiality,
Invention Assignment, and Non-Competition Agreement effective as of September 8, 2009 (the “Protective Covenant Agreement”), the Employee will not be held criminally or civilly liable under any federal or state trade secret law
for the disclosure of a Company trade secret if, and only to the extent that, such disclosure is made: (i) directly or indirectly and in confidence to a Government Agency, government official, or an attorney, solely for the sole purpose of
reporting or investigating the Company’s or other Released Party’s suspected violation of law; or (ii) in a complaint or other document filed under seal in a lawsuit or other proceeding against the Company or another Released Party.

  

	 	e)	Nothing in this Agreement authorizes or limits the Employee’s liability for any act that otherwise is prohibited by law, such as accessing or obtaining a Company trade secret or confidential information by
unauthorized means. 

 11.   Tax Treatment. The Company makes no representations or warranties to the Employee
regarding the tax treatment of the payments and benefits provided under this Agreement. The Employee is solely responsible for all federal, state, and local income and any other taxes that may be due on account of these payments and benefits. The
Company will apply payroll withholdings to certain payments and benefits that the Company reasonably believes are required by law or elected or authorized by the Employee for state and federal income taxes, Social Security, Medicare, and other
applicable payroll deductions, in accordance with the Company’s normal payroll practices. Severance pay is not eligible compensation under the Company’s 401(k) plan. 

12.   Compliance with Prior Agreements and Protective Covenant Agreement. The Employee remains bound by the terms of any prior
agreement with the Company relating to any inventions assignment, confidentiality, conflicting interest, non-disclosure or non-compete obligation including, without limitation, the Protective Covenant Agreement under which, among other covenants,
the Employee agreed to a 12-month restriction on competitive activities and the solicitation of customers, prospects and Company employees. 

13.   No-Hire Agreement. In addition to the Employee’s non-solicitation and other obligations under the Protective Covenant
Agreement, the Employee agrees, for a period of 12 months from and after the Separation Date, not to, directly or indirectly, alone or on behalf of any person or entity, hire any person who is an employee of the Company as of the Separation Date, or
who subsequently becomes an employee of the Company, without the prior written consent of the Company. In addition, the Employee agrees not to, directly or indirectly, assist any person or entity in performing any activity prohibited by this
Section 13 or any provision of the Protective Covenant Agreement. 
 14.   Agreement to Cooperate in Transition. Both
before and after the Separation Date, the Employee agrees to cooperate in all reasonable respects with the Company in its efforts to transition the Employee’s role and to work with employees and customers of the Company with respect to the same
as requested by the Company. Notwithstanding the generality of the foregoing and in furtherance of the foregoing, the Employee agrees to be available, at the 

  
 7 

 
Company’s reasonable request, (a) by telephone or e-mail (as directed by the Company), upon reasonable advance notice (notice in excess of 24 hours not being required), to answer any
questions that may arise relating to the Employee’s employment with the Company and the transition of his duties and responsibilities to such other persons as directed by the Company and (b) upon reasonable advance notice and at the
Company’s expense, to travel to meet with employees and/or customers of the Company for the same transition purpose or, at the Company’s option, to conduct such meetings via telephone or teleconference. 

15.   Cooperation with Legal Matters. The Employee agrees to cooperate with the Company and its designated attorneys,
representatives, and agents in connection with any actual or threatened judicial, administrative or other legal or equitable proceeding in which the Company is or may become involved. Upon reasonable notice, the Employee agrees to meet with and
provide to the Company or its attorneys, representatives or agents all information and knowledge that the Employee may have relating to the subject matter of any such proceeding. The Company agrees to reimburse the Employee for any pre-approved
reasonable costs incurred by the Employee in providing such cooperation. 
 16.   Non-Disparagement. The Employee
represents and warrants that the Employee has made no critical, disparaging or defamatory comments regarding Company. The Employee further agrees that the Employee will not in the future participate or engage in any trade or commercial
disparagement of the business or operations of the Company and/or disparage the professional and/or personal lives of any individual manager, officer, employee or director of the Company, or give interviews, provide comment, information or opinions,
positive or negative, to any publicly available media resource or employee, contractor or representative, regardless of the format and intent of that media. This includes comments and communications via email, text message, Twitter, Facebook or
other social media.  
 17.   Return of Property. The Employee will return any and all Company computers,
notebook and tablet computers, mobile phones, smartphones, thumb drives, access cards, keys, reports, manuals, records, product samples, truck stock, office equipment and office supplies. The Employee will return and may not retain in any form, on
or before the Separation Date, all Company Documents and Data in the Employee’s possession or control. After returning Company Documents and Data, the Employee will permanently delete from any electronic media in the Employee’s possession,
custody, or control (such as computers, mobile phones, smartphones, personal digital assistants, other hand-held devices, mp3 players, iPads, back-up devices, zip drives, etc.) or to which the Employee has access (such as remote email exchange
servers, back-up servers, off-site storage, the cloud, etc.), all Company Documents and Data stored in any medium from which such information can be obtained. The Employee will provide the Company with the passwords to any password-protected
documents that the Employee created or is otherwise aware. 
 18.   Non-Admissions. The Parties deny liability or
wrongdoing toward each other and agree that nothing in this Agreement will be deemed to represent any concession or admission of such liability or wrongdoing or any waiver of any defense. 

  
 8 

 19.   Non-Assignment. The Employee agrees that the Employee has not assigned or
transferred in any manner, or purported to assign or transfer in any manner, to any person or entity, any claim or interest that is the subject of this Agreement. 

20.   Beneficiaries, Successors and Assigns. This Agreement will be binding on any successor or assignee of the
Company’s business or operations and any such successor or assignee will be a beneficiary of this Agreement and may rely on and enforce this Agreement to secure or defend its rights. 

21.   Governing Law and Forum. The Parties agree that this Agreement is to be interpreted in accordance with applicable federal
laws and the laws of the State of Minnesota, without regard to conflict of law principles of any jurisdiction. In the event of a controversy, claim or dispute between the Parties arising out of or relating to the enforceability of this Agreement,
the Employee’s right to challenge the knowing and voluntary nature of the waiver and release of Claims under the ADEA or the OWBPA, or the Company’s compliance with the waiver requirements of the ADEA or the OWBPA, the controversy, claim
or dispute must be filed exclusively in state or federal court in Hennepin County, Minnesota. All other controversies, claims or disputes between the Parties arising under or in connection with this Agreement will be settled exclusively by binding
arbitration administered by the American Arbitration Association in Minneapolis, Minnesota in accordance with the Commercial Arbitration Rules of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator’s
award in any court having jurisdiction. 
 22.   Remedies. The Employee understands that in the event of a violation by the
Employee of any provision of this Agreement or the Protective Covenant Agreement, the Company has the right to seek injunctive relief, in addition to any other remedies provided by law including actual, incidental and consequential damages, without
the requirement of posting bond. The Employee also agrees that the Company will be entitled to an accounting, and to the repayment of all profits, compensation, commissions, fees, royalties, or other financial rewards which the Employee or any other
entity or person may realize as a result of the Employee’s violations of these agreements. The Employee will reimburse the Company for all costs, expenses or damages that it incurs as a result of any violation by the Employee of any provision
of these agreements, including court costs, litigation expenses, and reasonable attorneys’ fees. 
 23.   Specific Remedies for
Employee Breach of Certain Covenants. Without limiting the rights and remedies available to the Company, in the event of any breach by the Employee of the covenants set forth in Sections 12, 13 or 16 of this Agreement or the terms of
the Protective Covenant Agreement, the following actions may be taken by the Company: 
  

	 	a)	If the Company believes a breach has occurred, it will deliver to the Employee a summary of the breach and a demand for explanation or agreement that such breach has occurred; the Employee will have ten
(10) business days to respond in writing to this demand, whereupon the Company will make a decision as to whether the breach has, in fact, occurred; if it is determined such a breach has occurred, then 

 

	 	i)	the Company’s obligation to make any payment or provide any benefits to the Employee under Section 5 of this Agreement will cease immediately and permanently, which will not have any impact whatsoever on the
Employee’s continuing obligations under the above-referenced covenants or the Protective Covenant Agreement; and 

  
 9 

	 	ii)	the Employee will repay to the Company, within ten (10) days after the Employee receives written demand therefore, an amount equal to ninety percent (90%) of the payments and benefits previously received by
the Employee under this Agreement, plus interest on such amount at an annual rate equal to the lesser of ten percent (10%) or the maximum non-usurious rate under applicable law, from the dates on which such payments and benefits were received
to the date of repayment to the Company. 

  

	 	b)	It is the desire and intent of the Parties that the provisions of Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement be enforced to the fullest extent permissible under the applicable laws in
each jurisdiction in which enforcement is sought. Accordingly, if any portion of Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement is adjudicated to be invalid or unenforceable, Sections 12, 13 and 16 of this
Agreement and the Protective Covenant Agreement will be deemed curtailed, whether as to time or location, to the minimum extent required for its validity under applicable law and will be binding and enforceable with respect to the Employee as so
curtailed, such curtailment to apply only with respect to the operation of Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement in the jurisdiction in which such adjudication is made. If a court in any jurisdiction, in
adjudicating the validity of Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement, imposes any additional terms or restrictions with respect to Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement,
Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement will be deemed amended to incorporate such additional terms or restrictions. 

  

	 	c)	The Employee agrees and acknowledges that the Employee has received good and adequate consideration for the covenants set forth in Sections 12, 13 and 16 of this Agreement and the Protective Covenant Agreement in the
form of employment, compensation, and benefits separate and independent of any payments or potential payments in this Agreement. 

24.   Construction, Invalidity and Severability. Whenever possible, each provision of this Agreement must be interpreted as to be
valid under applicable law. If any provision of this Agreement is to any extent deemed invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions contained in this Agreement will not be affected or
impaired. To the extent permitted and possible, the invalid or unenforceable term will be deemed to be replaced by a term that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term. An
adjudication of full or partial invalidity, illegality or unenforceability in one jurisdiction is not binding in other jurisdictions. 

25.   Entire Agreement; Modifications. Except for any continuing obligations of the Employee under the Indemnification Agreement
and the Protective Covenant Agreement as confirmed in Section 12 of this Agreement, this Agreement constitutes the entire agreement between the Company and the Employee relating to the Employee’s employment and separation

  
 10 

 
from employment with the Company and supersedes and replaces any prior agreement relating to such matters between the Parties, including without limitation that certain Severance Agreement dated
as of January 1, 2015 between the Parties. The Employee understands that this Agreement cannot be changed unless done in writing and manually signed by both the Company and the Employee. 

26.   Employee Acknowledgments. The Employee affirms that the Employee has read this Agreement and understands all of its terms,
has been advised by the Company to consult with an attorney and has had a sufficient opportunity to review this Agreement with the Employee’s attorney, if any. The Employee states that the Employee enters into this Agreement voluntarily with a
complete understanding of the Employee’s legal rights and obligations. The Employee states that no promise or inducement has been offered by the Company except as set forth in this Agreement and that the Employee is signing this Agreement
without relying on any statement or representation by the Company or any representative or agent of the Company. The Employee states that the Employee has full legal authority to release the Employee’s Claims. The Employee understands that this
Agreement will have a final and binding effect and that by executing this Agreement, the Employee may be giving up the Employee’s legal rights. 

[Remainder of page intentionally left blank; signature page follows] 

  
 11 

 IN WITNESS WHEREOF, the Company and the Employee have executed this Agreement effective as of the
date set forth below. 
  

							
		 		 	 ENTELLUS MEDICAL, INC.
  

			
	Dated: 12/30/16	 		 	 /s/ Brent A. Moen

		 		 	By: 	 	Brent A. Moen
		 		 	Its:	 	Chief Financial Officer
			
		 		 	  
 EMPLOYEE:

 

			
	Dated: 12/30/16	 		 	 /s/ James D. Surek

		 		 	By: 	 	James D. Surek

  
 12 

 Exhibit A 

Vested Stock Options 
  

											
	
Grant No.
  
	  	 Grant Date

 
	  	 Plan

 
	  	 Vested Options as of
Separation
Date
  
	  	 Exercise

Price
  
	  	  

New
Termination
Date
  

	  

001376
  
	  	  
 01/04/2016

 
	  	  
 2015/NQ

 
	  	  

  7,500
  
	  	  
 $16.99

 
	  	  

07/05/17
  

	  

1130    

 
	  	  
 12/16/2014

 
	  	  
 2006/NQ

 
	  	  
 22,137

 
	  	  
 $11.36

 
	  	  

07/05/17
  

  
 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]